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ABSTRACT 
 
Listeria monocytogenes is a human food borne pathogen that may cause, 
in particular in immunocompromised individuals, a severe disease characterized 
by septicemias, meningitis, meningo-encephalitis and abortions in pregnant 
women. The study of the cell biology of the L. monocytogenes infectious process 
provided insights in the way bacteria manipulate the host and revealed 
unsuspected functions of cellular proteins. To cause infection pathogens interfere 
with crucial host intracellular pathways, and different pathogens often hijack the 
same signaling pathways. In particular, host phosphorylation cascades are 
preferential targets of infecting bacteria. 
In this study, using L. monocytogenes as a pathogen model, we showed 
that eukaryotic cells present a variable protein phosphorylation pattern upon 
infection. We addressed in particular the tyrosine-phosphorylated protein profile 
triggered by Listeria infection and identified the motor protein, non-muscle myosin 
heavy chain IIA (NMHC-IIA) and the epithelial keratin 18 (K18), as differentially 
tyrosine-phosphorylated in response to Listeria uptake. 
We demonstrated that NMHC-IIA and K18 are tyrosine-phosphorylated over 
the time of infection and recruited at the bacterial entry site. In addition, we were 
able to show that the inhibition of myosin IIA activity affected the number of 
intracellular Listeria in non-phagocytic cells. The reduction of NMHC-IIA 
expression using RNAi techniques resulted in an increased Listeria uptake. 
Reversely, K18 knockdown lead to a significant decrease in bacterial entry.  
Together, these data unravel a novel role for the non-muscle myosin II 
class and for keratins in the Listeria cellular infection. In particular, they correlate 
for the first time myosin and keratin tyrosine-phosphorylation with Listeria entry 
into host cells. In addition, results obtained with EPEC, EHEC and Yersinia 
infection models further support a broader role of NMHC-IIA in bacterial infection. 
To better understand this role, we have identified potential NMHC-IIA-interacting 
partners, which are currently being characterized in the context of infection. 
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RESUMO 
 
Listeria monocytogenes é uma bactéria patogénica responsável pela 
listeriose humana. Esta doença infecciosa afecta sobretudo indivíduos 
imunocomprometidos nos quais se manifesta como meningite, encefalite, 
septicemia ou, em mulheres grávidas, aborto ou complicações neonatais. O 
estudo do processo infeccioso de Listeria clarificou o modo como as bactérias 
manipulam o hospedeiro e desvendou a função de inúmeras proteínas celulares, 
até então desconhecida. Para causar infecção, microrganismos patogénicos 
interferem com mecanismos intracelulares cruciais do hospedeiro, e em algumas 
ocasiões, o mesmo mecanismo é sequestrado por patógenos diferentes. Neste 
caso, as cascatas de fosforilação intracelulares são alvos preferenciais. 
Neste estudo, mostrámos que células eucariotas apresentam um padrão 
de fosforilação de proteínas intracelulares variável em resposta à infecção por 
Listeria monocytogenes. Analisámos especificamente o padrão de fosforilação em 
resíduos de tirosina que nos permitiu identificar uma proteína motora, a cadeia 
pesada da miosina IIA não-muscular (NMHC-IIA), e a forma epitelial da queratina 
18 (K18), como sendo diferencialmente fosforiladas em tirosina em resposta à 
entrada de Listeria. Demonstrámos que a NMHC-IIA e a K18 são fosforiladas em 
tirosina ao longo do período de infecção e recrutadas para o local de entrada da 
bactéria. Mostrámos que a inibição da actividade da miosina IIA afectava o 
número de bactérias no interior de células não-fagocíticas. A diminuição dos 
níveis de expressão intracelular da NMHC-IIA, por técnicas de RNA de 
interferência, resultou num aumento da entrada de Listeria nas células 
hospedeiras. Em contraste, a redução da expressão de K18 teve como 
consequência um decréscimo na eficiência de entrada. 
            Em suma, estes dados permitiram desvendar a participação da classe das 
miosinas II não-musculares e das queratinas no processo celular de infecção por 
Listeria. Em particular, conseguimos correlacionar, pela primeira vez, a 
fosforilação em tirosina de miosinas e queratinas com o mecanismo de entrada de 
Listeria. Resultados obtidos com estudos de infecção por EPEC, EHEC e Yersinia 
contribuíram para reforçar o papel abrangente da NMHC-IIA na infecção por 
bactérias. Para melhor compreender este papel, identificamos novos potenciais 
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parceiros de interacção da NMHC-IIA, cujo papel no contexto de infecção por 
Listeria está a ser actualmente caracterizado. 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
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I. BACTERIAL PATHOGENS 
 
Bacteria do not possess membrane-bound organelles and thus have a 
disorganized intracellular compartment, characteristics that include them in the 
group of prokaryotic organisms. They exist in different shapes and their sizes vary 
within the micrometer range. Bacteria can be found in a wide range of 
environmental niches (e.g. soil, rock, oceans, and even arctic snow), where they 
play an important role in the cycling of nutrients. Some species live in association 
with more complex organisms, such as plants and animals, including humans. 
Despite their traditional association with disease, relatively few bacterial species 
are truly pathogenic for plants and animals.  
Humans live in close association with bacteria, and in most cases this 
interaction is important for a healthy life. In particular, symbiotic bacteria live in an 
intimate association with their hosts, as both co-existing organisms take important 
benefits from this relationship. In contrast, pathogenic bacteria can harm and 
directly cause disease to their hosts, through the concerted action of virulence 
factors 
 For the purpose of this thesis, bacterial pathogens from two different 
groups, representing both intracellular and extracellular species, were used as 
infection models. Their main features and mechanisms of virulence and cellular 
infection are described in the following sections. 
 
I.A. Listeria monocytogenes 
 
I.A.1. Overview 
 
Listeria monocytogenes (Lm) was first isolated in 1926 by E.G.D. Murray 
and his colleagues after an outbreak in an animal care house in Cambridge 
(Murray et al. 1926, Pirie 1927). Human cases were first reported in 1929 but for a 
long time listeriosis was considered a zoonosis. The first human outbreak and the 
direct association to the consumption of Lm-contaminated food was reported in 
1983 (Schlech et al. 1983). Lm is now recognized as a food borne pathogen 
mostly affecting industrialized countries due to the consumption of processed 
foods but becoming a worldwide concern as a result of an increase of elderly 
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population and immunosuppressed individuals (de Noordhout et al. 2014). Foods 
most frequently contaminated are industrially produced, refrigerated ready-to-eat 
products that are consumed without cooking or reheating. Listeriosis outbreaks 
were associated with the consumption of soft cheeses and dairy products, pâtés 
and sausages, smoked fish, salads and “delicatessen” (Swaminathan and Gerner-
Smidt 2007).  
Lm is a facultative anaerobic Gram-positive bacillus, included within the 
genus Listeria, which comprises 15 species (Graves et al. 2010, Leclercq et al. 
2010, Bertsch et al. 2013, Lang Halter et al. 2013, Liu 2013, den Bakker et al. 
2014). Together with Lm, nine other species are currently recognized: L. ivanovii, 
L. seeligeri, L. innocua, L. welshimeri, L. grayi, L. marthii, L. rocourtiae, L. 
fleischmannii and L. weihenstephanensis (Liu 2006, Graves et al. 2010, Leclercq 
et al. 2010, Bertsch et al. 2013, den Bakker et al. 2013, Lang Halter et al. 2013). 
Lm and L. ivanovii are the only pathogenic species, with Lm infecting humans and 
other animals, whereas L. ivanovii affecting primarily sheep and cattle. The other 
species live as non-pathogenic saprophytes (Glaser et al. 2001, Buchrieser et al. 
2003, Nelson et al. 2004, Schmid et al. 2005, Hain et al. 2006, Steinweg et al. 
2010, Buchrieser et al. 2011, Hain et al. 2012). Nonetheless, non-pathogenic 
Listeria species have been implicated in human infections, particularly in patients 
with a weakened immune system and/or with an underlying disease (Rocourt et al. 
1986, Andre and Genicot 1987, Cummins et al. 1994, Lessing et al. 1994, 
Todeschini et al. 1998, Perrin et al. 2003, Snapir et al. 2006, Rapose et al. 2008, 
Guillet et al. 2010, Salimnia et al. 2010). More recently, five new species have 
been proposed to the scientific community (L. aquatica, L. floridensis, L. 
cornellensis, L. grandesis and L. riparia), which have not been associated with 
pathogenicity (den Bakker et al. 2014).  
Lm is ubiquitously distributed in nature, being found in soil, water, plants, 
and food processing plants. This environmental widespreadness reflects its 
capacity to live under harsh conditions. Indeed, Lm can survive and even 
proliferate in high salt concentrations (up to 20%), at pH values ranging from 4.5 to 
9, and in a broad temperature range (1-45 ºC). Lm exhibits motility at 
environmental temperatures (up to 30 ºC) due to the presence of flagella. 
However, once inside a host organism, in order to avoid detection by the immune 
system, expression of the immunostimulatory flagella is repressed in a thermo-
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dependent manner (Way et al. 2004). These remarkable properties that allow Lm 
to be present in different environments, increase the risk of infection in humans 
and animals as a result of a routinely exposure to this pathogen. This makes Lm a 
serious threat to food safety and ranks it among the microorganisms that most 
concern the food industry (Vazquez-Boland et al. 2001, Khelef et al. 2006). 
 
I.A.2. Listeriosis 
  
Listeriosis manifests after ingestion of highly contaminated food (Vazquez-
Boland et al. 2001, Wing and Gregory 2002). In 2009, the incidence of listeriosis in 
Europe was 4 cases per million inhabitants, according to a report by the European 
Food Safety Authority. Listeriosis is a rare disease but considered to be under-
diagnosed because in some countries it is not a reportable disease, as it was the 
case in Portugal until this year. In Portugal, scarce reports only allow limited 
incidence determination of the disease during restricted periods of time. The most 
recent report of listeriosis in Portugal (2007) indicates an incidence of 2.3 cases 
per million inhabitants (Almeida et al. 2010), an increased value in comparison 
with reports in 2003 that established an incidence of 1.4 cases per million 
habitants (Almeida et al. 2006). In addition, antibiotic resistance was demonstrated 
to be increasing in both food and clinical Lm isolates in a recent Portuguese study 
(Barbosa et al. 2013). 
Lm can be asymptomatically present in the gastro-intestinal tract of healthy 
humans. Although the incubation time is relatively long, varying from 1 to 67 days 
in healthy individuals, listeriosis can occur in less than 24 hours as febrile 
gastroenteritis (Goulet et al. 2013). Other form of the disease can also manifests 
as a cutaneous infection. Both manifestations are non-invasive forms, which 
usually resolve spontaneously.  
Lm may also cause a more severe form of the disease (invasive listeriosis) 
that primarily affects immunocompromised hosts, which include risk groups such 
as elderly, pregnant women and newborns (Lecuit 2007, Allerberger and Wagner 
2010). The majority of invasive listeriosis cases manifest in three possibly life-
threatening clinical forms: (i) septicemia, (ii) meningo-encephalitis, and (iii) 
materno-fetal or neonatal infections. The average case-fatality rate can be as high 
as 30%. The major line of defense against listeriosis is cell-mediated immunity, 
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explaining the fact that individuals with T-cell dysfunction are prone to contract the 
disease (Swaminathan and Gerner-Smidt 2007). 
Lm is naturally susceptible to a variety of antibiotics, such as penicilins, 
aminoglycosides, trimethoprim, tetracycline, macrolides, and vancomycin. 
Treatment of invasive listeriosis requires ampicillin, and in specific cases 
(bacteremia, meningitis, endocarditis), combination therapeutics with an 
aminoglycoside (gentamicin) has revealed to have a synergistic effect (Temple 
and Nahata 2000). Ampicilin is also used in clinical treatment of pregnancy-
associated listeriosis (Charlier and Lecuit 2014), with a common duration of 21 
days (Pereira et al. 2013).  
Human invasive listeriosis develops through successive steps (Figure 1), 
beginning with the ingestion of contaminated food. Lm resists to the acidic gastric 
fluids and reaches the intestinal lumen, where it invades the mucus-secreting 
goblet cells, to cross the intestinal barrier (Lecuit et al. 2001, Nikitas et al. 2011). It 
is then thought to disseminate from the mesenteric lymph nodes, via lymph and 
blood circulation, reaching the liver and the spleen, where Lm can survive and 
replicate exponentially. A second more severe stage of the infection is achieved 
when Lm is able to reach the brain or the placenta, by crossing the blood-brain or 
the placental barriers, respectively. This infection outcome is responsible for the 
cases of meningitis or encephalitis in immunocompromised patients, abortions in 
pregnant women, and septicemia in infected neonates (Lecuit 2007, Allerberger 
and Wagner 2010). 
 
 
Figure 1. Successive steps of the Lm in vivo infection. 
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I.A.3. Cellular infection cycle 
 
Lm is a facultative intracellular pathogen and the cell biology of its infectious 
process has been widely studied. A key feature of Lm is its capacity to induce its 
own internalization into non-phagocytic cells and to survive and multiply in the 
cytosol of most cell types, including enterocytes, hepatocytes, fibroblasts, 
endothelial cells or glial cells in CNS, and macrophages (Allerberger and Wagner 
2010, Cossart 2011). In addition, Lm exploits the host cell cytoskeleton to propel 
itself through the cytoplasm by means of an actin-dependent motility. In the later 
steps of the cellular infection, Lm interacts and pushes the host cell plasma 
membrane outward, forming protrusions that can penetrate and be engulfed by 
adjacent cells. This process allows Lm dissemination by direct cell-to-cell spread, 
without re-exposure to the extracellular environment and to extracellular immune 
defense players, such as antibodies and the complement system (Regan et al. 
2014). 
This infection cycle is carried out in a step-wise mode: (i) adhesion to the 
host cell surface, (ii) internalization, (iii) lysis of the primary vacuole, (iv) 
multiplication in the host cytoplasm, (v) actin-based intracellular movement, and 
(vi) intercellular spread (Figure 2). Lm evolved a variety of molecular weapons to 
exploit key cellular processes in order to successfully go through these steps. 
Indeed, many of its currently known and characterized virulence factors interact 
with particular cellular components and are involved in specific steps of the cellular 
infection (Camejo et al. 2011).  
 
(i) Adhesion to the host cell surface 
  
 The first step of cellular infection corresponds to the adhesion of Lm to the 
host cell surface. Several proteins expressed at the Lm surface (Figure 2) interact 
with target proteins expressed at the surface of the host cell (Bierne and Cossart 
2007). Lm becomes therefore closely associated to the host cell membrane and is 
then able to induce host signaling cascades to promote its uptake by the host cell 
(Pizarro-Cerda et al. 2012). Previous studies have demonstrated that decreased 
Lm adherence actually culminate in diminished bacterial virulence (Milohanic et al. 
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2001, Cabanes et al. 2004, Jagadeesan et al. 2010, Reis et al. 2010, Osanai et al. 
2013). 
 
(ii) Internalization 
  
 In vivo, as well as in in vitro-cultured cells, Lm can enter and survive inside 
professional phagocytic cells (Gray et al. 2006). Importantly, as described above, 
Lm upon adhesion induces its own internalization in non-phagocytic cells (Cossart 
2011).  
 Lm invades non-phagocytic cells using a zipper-like mechanism, 
characterized by multiple intimate interactions established between the bacterium 
and the host cell membrane (Isberg and Van Nhieu 1994, Swanson and Baer 
1995, Mengaud et al. 1996). This process is followed by a progressive 
invagination of the host plasma membrane leading to the consequent bacterial 
engulfment (Figure 2). The entry of Lm into host cells is a crucial step in its 
infection process and is therefore mediated by key virulence factors, such as the 
surface proteins and major Lm invasins, InlA and InlB (Figure 2), which will be 
described further on (Pizarro-Cerda et al. 2012). 
 
(iii) Lysis of the primary vacuole 
  
 Once internalized by the host cell, Lm resides in a single-membrane 
endocytic vacuole that quickly (20 minutes) undergoes acidification. This pH 
 
Figure 2. Schematic representation of the different steps of Lm cellular infection cycle. The 
major Lm virulence factors implicated in each step are indicated. 
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decrease promotes disruption of the vacuole by Lm through the secretion and 
activation of three bacterial proteins (LLO, PI-PLC and PC-PLC), which form pores 
in the vacuolar membrane and lead to the rupture of this compartment (Figure 2) 
(Geoffroy et al. 1987, Camilli et al. 1991, Geoffroy et al. 1991, Leimeister-Wachter 
et al. 1991, Mengaud et al. 1991, Goldfine and Knob 1992, Raveneau et al. 1992, 
Marquis and Hager 2000). 
 
(iv) Multiplication in the host cell cytoplasm 
  
 After lysing the internalization vacuole, Lm is released into the host cell 
cytoplasm, where the abundance of cytosolic nutrients enables the bacterium to 
grow and multiply exponentially (Figure 2). During this phase of the Lm 
intracellular life, the expression of several genes coding for metabolic and 
virulence determinants is induced, namely those required for nutrient uptake and 
further on for actin-based motility and cell-to-cell spread (Chatterjee et al. 2006, 
Camejo et al. 2009). 
 
(v) Actin-based intracellular movement 
  
 Lm is able to induce its own movement throughout the host cell cytoplasm 
by exploiting the host cellular machinery. Indeed, the bacterium begins recruiting 
and polymerizing host actin around its surface, forming an actin cloud that 
envelopes Lm. This structure is then progressively transformed into a long comet-
like tail localized at one of the bacterial poles (Figure 2). The constant polyrization 
and depolymerization of actin in this “comet tail” generates the driving force 
needed for bacterial movement in the host cytoplasm (Smith and Portnoy 1997).  
 
(vi) Intercellular spread 
  
 The Lm actin tail propels the bacterium randomly through the cytoplasm. 
Occasionally, Lm encounters cell periphery and, in some cases, it can push it 
outwards, generating a protrusion that contains the propelling bacterium at its tip 
(Figure 2). If this protrusion encounters the membrane of a neighboring cell, it can 
force its invagination and consequent engulfment by this cell, generating a double-
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membrane Lm-containing vacuole. This secondary vacuole can then be lysed in a 
similar fashion as the primary vacuole, liberating Lm into the cytoplasm and 
enabling the infection of a new host cell, thus restarting the cycle.  
 
I.A.4. Major virulence factors 
 
Some of the Lm virulence factors known to be involved in the different steps 
of the cellular infection cycle are indicated in Figure 2.  Although several other 
have been described and characterized I will describe in more detail some 
virulence factors that are representatives of each step of the infection cycle. 
 
I.A.4.1. Internalins A and B 
 
Internalins are key effectors for Lm invasion into the host cells (Bierne et al. 
2007). Nonetheless, other bacterial proteins also contribute for the efficiency of 
internalization, revealing a complex interaction between Lm and eukaryotic cells 
during the early steps of the cellular infection cycle (Cabanes et al. 2004, 
Dussurget et al. 2004, Cabanes et al. 2005, Reis et al. 2010). 
The internalization of Lm by non-phagocytic cells is mainly promoted by two 
members of the internalin family: internalin A (InlA) and B (InlB) (Figure 3) 
(Gaillard et al. 1991). The inlA and inlB genes are transcribed both individually and 
in an operon, and their expression is under the control of PrfA, the major 
transcriptional regulator of Lm virulence genes. 
InlA is a protein of 800 amino acid residues that is required for the invasion 
of epithelial cells expressing its cognate receptor, E-cadherin (described below). At 
the N-terminus, InlA has a canonical signal peptide sequence followed by a region 
of 15 leucine-rich repeats (LRRs) consisting of tandem repeats of 20-22 amino 
acids (Schubert et al. 2001, Bierne et al. 2007) enriched in leucine residues. The 
LRRs are present in different prokaryotic and eukaryotic proteins, providing 
recognition units for protein-protein interaction (Cabanes et al. 2002). An inter-
repeat region (IR) separates the LRR region from a second repeat region (B 
repeat). The C-terminus of InlA exhibits a cell wall-sorting LPXTG motif that allows 
its covalent linkage to the Lm peptidoglycan matrix (Figure 3). The LRR region is 
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both necessary and sufficient to promote Lm entry into epithelial cells (Lecuit et al. 
1997). 
InlB is a 630-amino acid protein involved in the entry of Lm into a broad 
range of cell types (Dramsi et al. 1995). Its N-terminal domain contains a signal 
peptide sequence that is followed by six LRRs, an IR region, and a B repeat 
significantly shorter than that of InlA. The C-terminal domain has three tandem 
repeats of about 80 amino acids, each containing the dipeptide GW (thus termed 
GW modules), which mediate the loose attachment of InlB to the Lm cell wall via a 
non-covalent interaction with lipoteichoic acids (Jonquieres et al. 1999) (Figure 3). 
Due to its labile association to the bacterial membrane, InlB can be released to the 
extracellular medium and act as a soluble factor, interfering with host cell 
signaling. The GW modules and the B repeat are also involved in interactions with 
the surface of host cells (Jonquieres et al. 2001). The LRR region of InlB is 
sufficient to confer invasiveness to non-invasive bacteria such as L. innocua 
(Braun et al. 1999, Jonquieres et al. 1999). 
 
 
I.A.4.2. Listeriolysin O and phospholipases 
 
 Listeriolysin O (LLO) is a cholesterol-dependent pore-forming toxin 
expressed by Lm, which plays a key role in the disruption of the primary and 
secondary vacuoles formed by internalization of Lm by host cells. Soon after 
internalization, the acidification of the Lm-containing vacuole allows LLO to reach 
its maximum activity (Geoffroy et al. 1987). As a consequence of pore formation, 
 
Figure 3. Schematic representation of InlA and InlB. LRRs: leucine-rich repeats; IR: inter-
repeat; B: B repeat; LPXTG: cell wall sorting motif allowing the covalent anchorage to the 
peptidoglycan; GW: GW modules allowing the labile association to the cell wall. 
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the vacuolar pH rises and LLO is progressively inactivated (Shaughnessy et al. 
2006), thus protecting further damage to other host cellular membranes. Recently, 
this major virulence factor has shown to be multifunctional, displaying both 
extracellular and intracellular roles during Lm infection aside from its primary 
function in vacuole disruption (Hamon et al. 2012, Seveau 2014). LLO triggers 
histone modifications prior to bacterial entry and, as a consequence, down-
regulates a subset of genes that includes immunity-related genes (Hamon et al. 
2007, Hamon and Cossart 2011). Moreover, LLO has been shown to interfere with 
SUMOylation of host proteins to favor infection (Ribet et al. 2010). Recently, an 
alternative Lm internalization pathway has been proposed, implicating LLO in this 
process (Vadia and Seveau 2014).  
In addition to LLO, the lysis of primary and secondary vacuoles also 
involves two secreted phospholipases. PlcA, a phosphatidylinositol-specific 
phospholipase C (PI-PLC) is implicated in the disruption of the primary vacuole 
(Camilli et al. 1991, Geoffroy et al. 1991, Leimeister-Wachter et al. 1991, Mengaud 
et al. 1991, Goldfine and Knob 1992), while PlcB, a phosphatidylcholine-specific 
phospholipase C (PC-PLC) plays an preponderant role in the disruption of the 
double-membrane secondary vacuole. The activation of PlcB requires the 
proteolytic cleavage of its immature precursor by the metalloprotease Mpl 
(Domann et al. 1991, Raveneau et al. 1992, Marquis and Hager 2000). 
 
I.A.4.3. Actin assembly-inducing protein 
  
The intracellular motility of Lm relies on the activity of the actin assembly-
inducing protein (ActA) (Domann et al. 1992, Kocks et al. 1992). This 639-amino 
acid surface protein exhibits an N-terminal signal peptide and a C-terminal 
transmembrane hydrophobic sequence that enable the respective targeting and 
anchoring of ActA to the bacterial surface. ActA, recruits and directly activates host 
cell proteins involved in the polymerization and depolymerization of cytoskeletal 
actin filaments. Lm initially expresses ActA around the entire surface of the 
bacteria and actin-clouds formed and then relocalizes at one pole of the bacterium 
generating actin-comet-tails to allow intracellular movement (Figure 4).  
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I.A.4.4. PrfA 
 
Importantly, expression of the major Lm virulence factors is promoted by the 
transcriptional activator PrfA, a regulatory protein of 233 amino acids that belongs 
to the Crp/Fnr family (Sheehan et al. 1996, Khelef et al. 2006). Interestingly, the 
transcription of the gene encoding PrfA is thermo-regulated (Renzoni et al. 1997). 
At lower temperatures, the 5’ UTR of the prfA mRNA adopts a hairpin structure 
that prevents access to ribosomes and thus inhibits translation. At temperatures 
closer to 37 ºC, the 5’ UTR hairpin is destabilized, exposing the ribosome-binding 
site and enabling the translation of PrfA (Johansson et al. 2002). This regulatory 
mechanism ensures that the expression of Lm virulence factors is only promoted 
in the context of the host, at 37 ºC (Figure 5). 
Host cell invasion is critical for listeriosis pathology due to its requirement 
for the initial crossing of the host intestinal barrier and further colonization of 
diverse target organs. It is therefore crucial to comprehend how Lm induces its 
 
Figure 4. Lm-infected cells showing actin comet tails. Image from Molecular Microbiology 
Group: green: actin; red: Lm; blue: nuclei. 
 
Figure 5. Thermoregulated expression of PrfA (Adapted from (Johansson et al. 2002) 
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own uptake by host cells. Previous studies revealed the complexity of interactions 
between multiple bacterial and host factors during the entry process, helping to 
better understand the molecular basis of the tissue tropism of Lm (Seveau et al. 
2007). Some of these interactions will be described in more detail in Chapter II of 
the introduction. 
 
I.B. Enterobacteriaceae 
 
The Enterobacteriaceae family constitutes the largest and most 
heterogeneous group of clinically relevant Gram-negative rod-shaped bacteria. Its 
members can be found in the soil, water or vegetation, but are also part of the 
intestinal microbiota of animals, including humans. Although a very diverse group 
of bacteria, only a few of its member species are actually pathogenic (Farmer 
2003). 
 
I.B.1. Yersinia  
 
The genus Yersinia comprises 11 species, of which only three are 
pathogenic for animals (including humans): Y. enterolitica, Y. pseudotuberculosis, 
and Y. pestis. Yersinia species are facultative anaerobic and non-sporulating rods 
or coccobacilli that can grow at temperatures ranging from 4 to 40 ºC (Nihlén 
1969). Like Lm, Y. enterolitica and Y. pseudotuberculosis are motile at 25 ºC due 
to the presence of flagella that is not expressed at 37 ºC. Once inside its host 
Yersinia becomes non-motile (Boyce 1985). 
Genetic studies suggest that Y. pestis is a subspecies that evolved from Y. 
pseudotuberculosis, while Y. enterolitica evolved through a different lineage 
(Chain et al. 2004). Therefore, Y. pestis showed a relatively recent evolution from 
a pathogen ubiquitously found in the environment and able to infect mammalian 
intestines, to an insect-transmitted mammalian blood-borne pathogen that causes 
plague, a highly fatal disease. Y. enterolitica and Y. pseudotuberculosis are either 
food- or water-borne pathogens that cause mainly self-limiting gastrointestinal and 
intestinal lymphoid system infections (Bottone 1997, Perry and Fetherston 1997, 
Sulakvelidze 2000, Carniel et al. 2002).  
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I.B.1.1. Yersiniosis  
 
Through the ingestion of contaminated food, Yersinia causes a human 
enteric infection called yersiniosis. This disease is more common in European 
countries with temperate climates, although it has been reported in all continents 
(Bottone 1999, Smego et al. 1999). In immunocompetent individuals, symptoms 
range from diarrhea, abdominal pain and fever to pseudo-appendicitis. Although 
this gastrointestinal infection is self-limiting, symptoms can become more 
aggravated. Septicemia caused by Yersinia infection, although rare has been 
reported with high mortality rate (75%) (Bottone 1997, Deacon et al. 2003). In 
immunocompromised patients, infection by Yersinia can develop to chronic 
conditions or autoimmune disease (Laitenen et al. 1972, Laitinen et al. 1977). 
Upon entering the host, bacteria that survived the acidic conditions of the stomach 
reach the intestine and are usually restricted to the small and proximal large 
intestine, Peyer’s patches and mesenteric lymph nodes (Young et al. 1996, Viboud 
and Bliska 2005). At the small intestine, Yersinia, attach and enter into M cells 
(Isberg and Barnes 2001). At the Peyer’s patches, bacteria replicate extracellularly 
and induce strong inflammation (Grassl et al. 2003). From Peyer’s patches, 
Yersinia disseminate via bloodstream inside phagocytes to mesenteric lymph 
nodes or other organs, such as liver and spleen, and even the central nervous 
system (Koornhof et al. 1999, Smego et al. 1999). At the target tissues, the 
extracellular replication of Yersinia originates microabcess lesions, in which 
bacteria resist to phagocytosis (Carniel et al. 2002). 
 
I.B.1.2. Cellular infection mechanisms 
 
Y. enterolitica and Y. pseudotuberculosis are well adapted to human 
infection. They are able to precisely regulate their virulence gene expression 
according to the particular conditions of the host environment, not only to 
potentiate their invasive capacity but also to modulate the host immune response 
in their own favor (Pepe et al. 1994). Pathogenic Yersinia spp. virulence genes are 
located both in the chromosome and in a 70-kb plasmid called pYV (for “plasmid 
involved in yersinial virulence”) (Portnoy and Falkow 1981, Revell and Miller 
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2001). The pathogenesis of Y. pseudotuberculosis was shown to require the 
presence of this virulence plasmid (Cornelis et al. 1989). 
 
(i) Adhesion to the host cell surface 
 
 The adhesion of Yersinia to host cells is mediated by bacterial adhesins 
and invasins either chromosomally- or plasmid-enconded, such as invasin (Inv), 
Yersinia adhesin A (YadA) and attachment and invasion locus (Ail) (Isberg and 
Falkow 1985, Miller and Falkow 1988, Bliska et al. 1993). 
Inv, the major invasin of enteropathogenic Yersinia, is a chromosomally 
encoded 103-kDa outer membrane protein that was shown to be sufficient to 
confer invasive capacity to non-invasive bacteria (Isberg and Falkow 1985). This 
invasion-promoting protein is not present in Y. pestis (Miller and Falkow 1988, 
Rosqvist et al. 1988). Inv binds to β1-integrins at the surface of M cells with higher 
affinity than fibronectin, the physiological integrin ligand (Isberg and Leong 1990, 
Hamburger et al. 1999). 
YadA is a surface adhesin of 45 kDa encoded in the pYV virulence plasmid 
of both Y. enterolitica and Y. pseudotuberculosis, but absent in Y. pestis. This 
multi-functional virulence factor confers both adhesive and invasive features to 
enteric Yersinia (Balligand et al. 1985, Kapperud et al. 1987, Martinez 1989, Eitel 
and Dersch 2002, Heise and Dersch 2006). Compared to other Yersinia species, 
YadA from Y. pseudotuberculosis binds with high affinity to fibronectin already 
bound to β1-integrins, promoting an uptake process similar to the one mediated by 
Inv (Heise and Dersch 2006). 
Ail is a 17-kDa chromosomally-encoded outer membrane protein that is 
sufficient to cause both attachment and entry of Y. enterolitica into cultured cells, 
and also contributes to serum resistance to complement-mediated killing (Miller et 
al. 1989, Miller et al. 1990, Pierson and Falkow 1993, Wachtel and Miller 1995). 
Although Ail promotes bacterial adhesion and invasion in cultured cells, disruption 
of the ail gene showed that this protein is not involved in virulence (Wachtel and 
Miller 1995, Yang et al. 1996). Functional redundancy between Ail, Inv and YadA 
might account for this lack of phenotype in vivo, suggesting a crucial role for these 
factors in disease. In Y. pseudotuberculosis, Ail does not contribute to adhesion 
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but still confers serum resistance (Ho et al. 2012, Ho et al. 2012). Virulence of Y. 
pestis requires Ail binding for effector delivery (Kolodziejek et al. 2012). 
 
 (ii) Delivery and secretion of virulence effectors 
 
The pYV virulence plasmid encodes a virulence effector delivery system, 
called type-three secretion system (TTSS). The yersinial TTSS comprises a basal 
body-like structure resembling that of the bacterial flagellum, which is topped by an 
extracellular needle-like appendage (injectisome) that protrudes outside the 
bacteria and contacts with the host cell membrane (Figure 6) (Thomas and Finlay 
2004). Upon bacterial adhesion to host cells, the injectisome is assembled and 
allows the direct transport of virulence effectors from the bacteria cytoplasm into 
the host cytoplasm (Portnoy and Falkow 1981, Cornelis and Wolf-Watz 1997). 
The TTSS or injects Yersinia outer proteins (Yops) directly into the host cell 
cytoplasm. Yops are exotoxins that mimic the activity of several host enzymes 
(e.g. phosphatases, proteases, kinases and acetylases) in order to subvert the 
host cytoskeleton and immune signaling pathways to favor infection (Table 1) 
(Cornelis 2002, Viboud and Bliska 2005). 
Besides three Yersinia species (Y. enterolitica, Y. pseudotuberculosis and 
Y. pestis), TTSS is found in a broad number of bacterial pathogens such as 
Bordetella bronchiseptica, Burkholderia pseudomallei, Chlamydia pitsitacii, Erwinia 
amylovora, Erwinia crysanthemi, pathogenic Escherichia coli, Pseudomonas 
aeruginosa, Pseudomonas syringae, Ralstonia solanacearum, Rhizobia spp., 
 
Figure 6. Schematic representation of TTSS injectisome. 
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Salmonella typhimurium, Shigella flexneri and Xanthomonas campestri (Hueck 
1998, Yuk et al. 1998, Winstanley et al. 1999) 
 
 
Table 1. Yersinia outer proteins (Yop) delivered to the host cell by TTSS. 
Effector Function References 
YopH Tyrosine phosphatase (Guan and Dixon 1990, Zhang et al. 1992) 
YopE Rho-GAP1 (Rosqvist et al. 1990) 
YopM Gene transcription2 
(Leung and Straley 1989, Skrzypek and 
Straley 1996, Skrzypek et al. 1998, Sauvonnet 
et al. 2002) 
YopJ Ubiquitin-like protease (Orth 2002) 
YopO Serine/Threonine kinase (Fallman et al. 1997, Juris et al. 2002) 
YopT Cyseine protease (Iriarte and Cornelis 1998) 
YopK Unknown function (Holmstrom et al. 1995, Holmstrom et al. 1995, Holmstrom et al. 1997) 
YopB TTSS structure (pore formation) (Rosqvist et al. 1994, Sory and Cornelis 1994, Boland et al. 1996, Hakansson et al. 1996) 
YopD TTSS structure (pore formation) (Rosqvist et al. 1994, Sory and Cornelis 1994, Boland et al. 1996) 
1 Rho-GTPase activating protein 
2 Function unknown; recent results on trafficking towards the nucleus might influence gene expression. 
 
(iii) Internalization 
 
Yersinia uptake is known to be mediated by β1 integrins. Integrins are 
eukaryotic heterodimeric αβ-protein receptors that mediate interactions between 
cells, cell-soluble protein, and cell-extracellular matrix (ECM) (Hynes 2002, Delon 
and Brown 2007). Depending on which α subunit it dimerizes with, the β1 integrin 
subunit can bind to different ECM ligands, to other cells, and to soluble ligands. 
Besides cognate interactions, β1 integrin also binds to ligands from viruses and 
bacteria, including Yersinia Inv (Hynes 1992, van der Flier and Sonnenberg 2001, 
Hynes 2002). At sites of adhesion, integrin clustering is triggered upon ligand 
binding, leading to the recruitment of signaling proteins. These signaling effectors 
establish an indirect connection of the actin cytoskeleton to the cytoplasmic 
domain of the integrin (Hynes 2002). This domain has no catalytic activity but 
recruits components that serve as linking or docking proteins for cytoskeleton-
associated elements (Pizarro-Cerda and Cossart 2006). 
Integrin engagement by Inv transmits biochemical signals and mechanical 
force across the cell membrane to favor invasion (Figure 7). Internalization of the 
activated receptor depends on downstream interactions of signaling molecules 
that result in rearrangements of the actin cytoskeleton beneath attached Yersinia. 
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Y. pseudotuberculosis induces binding and activation of the focal adhesion 
kinase (FAK) at the cytoplasmatic domain of integrin receptor (Schaller et al. 
1995). FAK tyrosine phosphorylation recruits and activates Src kinase that 
phosphorylates downstream effector molecules involved in cytoskeletal 
rearrangements. This FAK-Src complex regulates invasin-mediated invasion. 
(Alrutz and Isberg 1998, Bruce-Staskal et al. 2002). The interaction between Inv 
and integrin activates the small GTPases Rac1 and Arf6 also a membrane 
trafficking associated protein (Honda et al. 1999, Alrutz et al. 2001). In turn, these 
proteins promote the recruitment of the PI-5 kinase (PIP5K) to the bacterial entry 
site, inducing the local production of phosphatidylinositol biphosphate (PIP2) 
(Wong and Isberg 2003). PIP2 is an important second messenger that mediates 
the subcellular localization and activation of actin-dynamics regulators (Pizarro-
Cerda and Cossart 2004), such as N-WASP and its interacting partners, Nick and 
Grb2. In addition, Yersinia uptake is also modulated by a crosstalk between 
microtubules and Rho GTPases (McGee et al. 2001, McGee et al. 2003). 
 
(iv) Inhibition of phagocytosis 
 
It is important to mention that the invasive behavior of Y. enterocolitica and 
Y. pseudotuberculosis is only required during the initial stage of disease, to allow 
bacterial translocation from the lumen of the intestine to the underlying mucosal 
 
Figure 7. Schematic representation of the internalization process triggered by Yersinia. The 
interaction between Yersinia invasin and host cell integrins activates signaling cascades involving 
FAK and Src, which results in remodeling of the actin cytoskeleton to promote bacterial uptake. 
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tissue. In vivo, bacterial proliferation takes place in the extracellular space, thus to 
avoid phagocytosis, these species have developed an important arsenal of anti-
phagocytic Yops that are injected into target host immune cells to block the 
potential internalization of bacteria. After crossing the intestinal epithelium, 
macrophages and dendritic cells of the mucosa will target Yersinia therefore 
avoidance of phagocytosis is critical for bacterial survival.  
Upon injection into the host cell cytoplasm, Yop effectors inhibit signaling 
cascades involved in cytoskeleton dynamics by interfering with host actin-
regulating proteins, such as small GTPases (Rac1, RhoA and Cdc42) (Rosqvist et 
al. 1990, Hakansson et al. 1996, Iriarte and Cornelis 1998, Zumbihl et al. 1999, 
Barz et al. 2000, Black and Bliska 2000, Andor et al. 2001, Shao et al. 2002). 
Delivery of anti-phagocytic Yops is also mediated by β1 integrin activation 
(Bovallius and Nilsson 1975, Isberg 1989, Isberg et al. 2000, Fallman et al. 2002). 
Phosphatase activity of YopH (Table 1) dephosphorylates FAK inhibiting inv-
mediated uptake. Moreover YopE GAP function (Table 1) blocks Rac1 signaling 
inhibiting phagocytosis through the disruption of actin filaments (Black and Bliska 
2000).  
The ability to block invasion and further degradation within phagocytes 
relies on the expression of the virulence effectors YopH, YopE, YopO, and YopT, 
all encoded in the pYV virulence plasmid (Rosqvist et al. 1988, Rosqvist et al. 
1990).  
 
I.B.2. Pathogenic E. coli 
 
Escherichia coli (E. coli) is a facultative anaerobic, motile, non-sporulating, 
Gram-negative bacillus, with an optimal growth at 37 °C, although some laboratory 
strains can replicate at temperatures up to 49 °C (Kubitschek 1990, Kubitschek 
1990, Fotadar et al. 2005, Darnton et al. 2007). It is the primary facultative 
anaerobe of the normal intestinal microflora of humans and other mammals, 
adhering to the mucus layer of the large intestine. More than just a benign 
commensal, E. coli can acquire genetic elements encoding virulence factors, 
which enable its evolution into, often deadly, pathogenic strains. Several E. coli 
strains are known to cause intestinal and extra-intestinal diseases by tampering 
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with different host cellular processes, through the engagement of host signaling 
pathways. 
E. coli identification is based on O (somatic), H (flagellar), and K (capsular) 
surface antigen profiles, which are specific for different disease-associated 
serotypes (Lawn et al. 1977, Orskov and Orskov 1977, Orskov et al. 1977). Toxins 
and other virulence effectors allow the discrimination of diarrheagenic pathotypes 
from non-pathogenic and from extra-intestinal E. coli (Donnenberg et al. 1998, 
Nataro and Kaper 1998, Nataro and Martinez 1998, Kohler and Dobrindt 2011). 
Pathogenic E. coli are responsible for three types of infections in humans: urinary 
tract infections (UTI), neonatal meningitis, and intestinal diseases (gastroenteritis). 
Infections caused by a particular strain depend on the distribution and expression 
of virulence determinants, such as adhesins, invasins, toxins, as well as on the 
bacterial capacity to subvert host defense mechanisms.  
Different diarrheagenic E. coli types have been identified: enterotoxigenic E. 
coli (ETEC), enterohaemorrhagic E. coli (EHEC), enteropathogenic E. coli (EPEC), 
enteroinvasive E. coli (EIEC), and enteroaggregative E. coli (EAEC) (Table 2) 
(Nataro and Kaper 1998). E. coli strains were also isolated from other infections, 
such as uropathogenic E. coli (UPEC), neonatal meningitis-associated E. coli 
(NMEC) and sepsis-causing E. coli (SEPEC), which comprise the extra-intestinal 
group of pathogenic E. coli (Russo and Johnson 2000, Johnson and Russo 2002, 
Johnson et al. 2005, Smith et al. 2007).  
 
I.B.2.1. EPEC and EHEC 
 
EPEC and EHEC have different clinical manifestations and are a group of 
pathogens that are evolving and are still a challenge in public health. These 
Table 2. Diarrheagenic E. coli types, their target cells and effects. 
E. coli Target Effect 
EPEC Small bowel enterocytes A/E lesions causing inflammation and diarrhea 
EHEC Colon cells A/E lesions and systemic toxin absorption causing bloody diarrhea 
ETEC Small bowel enterocytes Enterotoxin secretion causing diarrhea 
EAEC Small and large bowel epithelia 
Cytotoxin and enterotoxin secretion causing mucosal 
damage and diarrhea 
EIEC Colon epithelial cells Intracellular pathogen causing inflammation, dysentery and diarrhea 
DAEC Small bowel enterocytes Cytopathic (cellular extensions) causing inflammation and diarrhea 
A/E lesions: attaching and effacing epithelial lesions 
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pathogens share the same mechanism adhesion to intestinal cells. EPEC and 
EHEC strains are responsible for the high frequency of intestinal disease (Nataro 
and Kaper 1998). Infection outbreaks in industrialized countries demonstrated that 
EHEC is a zoonotic strain (commensal in ruminants) that is transmitted through 
fecal contamination of water - food resources (vegetables). This develops human 
serious clinic events as hemorrhagic colitis (HUC), hemolysis and renal failure 
(HUS), witch are mediated by toxins (Shiga toxins) characteristic of EHEC. EPEC 
is more common in developing poor countries, and is the main cause of diarrhea in 
small children. EPEC as never been found in animals, and its only reservoir is 
humans. Toxin production is not an original characteristic of these human strains 
(Feng 2012, Hartland and Leong 2013).  
Host-pathogen interaction studies with EPEC and EHEC demonstrated that, 
upon colonization of intestinal epithelial cells, tightly adhered bacteria induce the 
formation of “attaching and effacing” (A/E) lesions (Knutton et al. 1989, Schauer 
and Falkow 1993, Marches et al. 2000, Donnenberg and Whittam 2001, Deng et 
al. 2003, Kaper et al. 2004, Mundy et al. 2005). These histopathological features 
are characterized by tight bacterial attachment to the epithelial cell surface 
resulting in the accumulation of filamentous F-actin-rich pedestal-like structures, 
which lift up the bacteria above the plane of the cell membrane (Staley et al. 1969, 
Ulshen and Rollo 1980, Moon et al. 1983). Actin-pedestals result from the 
destruction of the microvilli and are essential for colonization. These structures are 
formed in a TTSS-dependent manner upon translocation of bacterial effectors into 
the host cell (Figure 8) (Dean et al. 2005, Garmendia et al. 2005, Hayward et al. 
2006, Dean and Kenny 2009). 
 
Figure 8. Schematic representation of EPEC/EHEC-induced actin pedestal formation. 
 37 
I.B.2.1.1. Virulence effectors 
 
The EPEC/EHEC TTSS is encoded in the locus of enterocyte effacement 
(LEE), a 35-kb pathogenicity island that is absolutely required for intestinal 
colonization and A/E lesion formation (Jarvis et al. 1995, Elliott et al. 1998, Perna 
et al. 1998). The LEE of EPEC and EHEC is highly conserved and homologous to 
the ones found in other pathogens that also interfere with actin polymerization, 
such as Shigella, Salmonella and Yersinia (Sperandio et al. 1998, Coburn et al. 
2007). Besides TTSS components, the LEE encodes other bacterial effectors that 
depend on TTSS activity (Table 3). The first interaction of the bacteria with host 
cell is made trough contact of TTSS with enterocyte membrane by EspA-
containing filamentous organelle of EPEC (Knutton et al. 1998). 
 
Table 3. Pathogenic E. coli effectors and functions 
Pathotype Effector Function Activity/Effect 
EPEC, EHEC Intimin Adhesin Intimate attachment to epithelial cells; stimulates immune responses 
EHEC OmpA Adhesin Adhesion to epithelial cells 
EHEC Shiga toxin Toxin Inhibit protein synthesis; induces apoptosis 
EPEC, EHEC Tir Receptor  (Type III effector) 
Nucleation of cytoskeletal proteins; loss of 
microvilli; GAP-like activity 
EPEC EspC Autotransporter Ion secretion 
EHEC EspP Autotransporter Cleavage of coagulator factors 
EPEC, EHEC EspF Type III effector Opens tight junctions; induces apoptosis 
EPEC, EHEC EspH Type III effector Modulates filopodia and pedestal formation 
EPEC, EHEC Map Type III effector Disrupts mitochondrial membrane potential 
EHEC StcE Type II effector Disrupts complement cascade 
EHEC Ehx Toxin Cell lysis 
EPEC, EHEC LifA/Efa Toxin Inhibits lymphocyte activation, adhesion 
 
 The translocated intimin receptor (Tir) through TTSS is injected into the 
host cytoplasm and then integrates in the host cell membrane in a hairpin-like 
conformation (Jerse et al. 1990, de Grado et al. 1999, Batchelor et al. 2000). 
There, it functions as a receptor for intimin, a bacterial outer membrane adhesin 
that is encoded in the LEE operon (Jerse et al. 1990, de Grado et al. 1999, 
Batchelor et al. 2000). Intimin binds to the extracellular domain of Tir, inducing 
clustering of the receptor, while the cytoplasmic Tir-N and Tir-C domains trigger 
downstream signaling events that ultimately lead to actin polymerization beneath 
the attached bacteria (Kenny et al. 1997, Kenny and Finlay 1997, Deibel et al. 
1998, Campellone et al. 2004, Caron et al. 2006, Hayward et al. 2006). Tir-N as 
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been shown to bind proteins involved in actin assembly (α-actinin and cortactin), 
while Tir-C recruits actin polymerization components, such as the actin nucleator 
complex Arp2/3 and its activator N-WASP (Campellone et al. 2004, Campellone et 
al. 2006, Brady et al. 2007).  
The Tir-intimin interaction appears as a key event in both EPEC and EHEC 
infection, as pedestal formation may also inhibit phagocytosis and therefore 
contribute to immune evasion. Tight attachment of bacteria to the host cell 
membrane is not a static phenomenon. The dynamic actin polymerization and 
depolymerization occurring beneath adhered bacteria allow their movement along 
the host cell membrane (“surfing”) and contribute to cell-to-cell spread (Sanger et 
al. 1996). 
The EHEC effector EspFu is also translocated across the host cell 
membrane via TTSS. Upon the establishment of a Tir-intimin interaction and 
further Tir clustering, EspFu is recruited at the adhesion site, where it sequesters 
N-WASP (Campellone et al. 2004, Lommel et al. 2004, Garmendia et al. 2005, 
Campellone et al. 2006). EspFu is homologous to another LEE-encoded effector, 
EspF that also binds and activates N-WASP. EspF was found in EPEC and 
described to nucleate a host protein-signaling complex of sorting nexin-9 (SNX9). 
EspF and SNX9 appear as an alternative signaling pathway that induces 
membrane-remodeling events associated with N-WASP and Arp2/3 (Alto et al. 
2007, Cheng et al. 2008). 
EPEC and EHEC Tir proteins are highly similar both in structure and in 
function, although substitution of the EPEC Tir by that of EHEC results in a strong 
reduction of pedestal formation (DeVinney et al. 2001, Kenny 2001, Campellone et 
al. 2002). Both EPEC and EHEC Tir proteins are receptor tyrosine kinases (RTKs) 
phosphorylated upon intimin interaction, although the main difference resides in 
the identity of the phosphorylated tyrosine (Y) residue. EPEC infection induces Tir 
Y474 phosphorylation, which in turn recruits the adaptor protein Nck that binds 
and activates N-WASP and Arp2/3, resulting in actin pedestal formation 
(Gruenheid et al. 2001, Rohatgi et al. 2001, Campellone et al. 2004). On the other 
hand, EHEC infection induces Tir phosphorylation at the Y458 residue. This 
promotes the recruitment of the insulin receptor tyrosine kinase substrate (IRTKS), 
which in turn establishes the link between Tir and EspFu. The role of IRTKS in 
EHEC-mediated actin pedestal formation indicates that EHEC has evolved to use 
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a host protein to link two secreted effectors required for N-WASP- and Arp2/3-
driven actin polymerization (Campellone et al. 2002, Campellone and Leong 2003, 
Allen-Vercoe et al. 2006, Brady et al. 2007, Vingadassalom et al. 2009). 
EHEC infection is associated with hemolytic uremic syndrome (HUS) a life-
threatening infection characterized by hemolytic anemia, thrombocytopenia, and 
renal failure. HUS is caused by the action of Shiga-like toxin (Stx), an EHEC 
specific effector protein that cleaves ribosomal RNA (thus compromising protein 
translation) (Melton-Celsa et al. 1998). Stx is secreted in the colon and 
systemically disseminated to the kidneys, where it induces damage to renal 
endothelial cells (Andreoli et al. 2002). The O157:H7 serotype is responsible for 
this infection and the one that includes the most virulent strains (O'Brien et al. 
1992, Karmali 2004, Karch et al. 2005). 
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II. POST-TRANSLATIONAL MODIFICATIONS IN BACTERIAL INFECTION 
  
Cellular microbiology studies brought new evidence of how bacterial 
pathogens manipulate the host cell signaling machinery with high precision to 
promote and establish infection. In addition, these studies helped to characterize 
and understand cell biology processes. Despite their evolutionary divergence, 
different bacterial effectors often target the same host pathways. Several 
pathogens have been good models to understand what is currently known 
regarding protein-protein interactions, protein post-translational modifications 
(PTMs), and protein signaling cascades (Haglund and Welch 2011).  
Control of the activity level of proteins is achieved through the introduction 
of PTMs, i.e. modifications of specific amino acid residues with biochemical 
groups, which typically results in either the activation or inactivation of these 
proteins. PTMs, which can be reversible or irreversible, are often elicited in 
response to different environmental triggers. The extreme importance of this level 
of protein activity regulation makes PTMs a preferential target mechanism for 
bacterial pathogens. The most frequent PTMs targeted directly or indirectly by 
bacterial pathogens have been reviewed: phosphorylation, ubiquitination, 
SUMOylation, AMPylation, ADP-ribosylation, acetylation, amidation and 
proteolysis (Ribet and Cossart 2010, Ribet and Cossart 2010). Phosphorylation, 
as a mechanism of protein activity regulation, will be presented in more detail 
regarding the context of this work. 
 
II.A. Protein phosphorylation 
 
Bacterial pathogens have evolved a whole array of virulence factors that 
hijack the host cell machinery to create a suitable niche for their survival and 
proliferation. In general bacterial surface proteins that mediate the attachment to 
host cell through the interaction with surface receptors trigger signaling events that 
promote close bacteria-host association and/or bacterial internalization. There are 
some bacterial interactions that particularly induce plasma membrane remodeling 
and cytoskeletal rearrangements (Mattoo et al. 2007). A strategy used by many 
pathogens is to interfere with the phosphorylation cascades of intracellular host 
signaling pathways (Bhavsar et al. 2007).  
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Addition of a phosphate group (from ATP) to specific amino acids 
(serine/threonine/tyrosine) is the hallmark of the reversible protein modification 
mechanism catalyzed by kinases. Sequential phosphorylation or 
dephosphorylation events occur within signaling cascades to activate or inactivate 
host kinases as well as their substrates. The dephosphorylation of these signaling 
components is driven by phosphatases, which hydrolyse the existing 
phosphoester bond. 
Bacterial pathogens commonly hijack host cell phosphorylation machinery 
during infection. Bacterial effectors can directly phosphorylate host proteins, or 
requires host kinases to mediate target phospohorylation. In addition, there are 
examples of bacterial effectors that also exhibit phosphatase activity (Bliska et al. 
1991, Viboud and Bliska 2005, Navarro et al. 2007). 
 
II.A.1. Protein phosphorylation in Listeria monocytogenes infection 
 
As previously mentioned, InlA and InlB are the major Lm surface-
associated proteins that promote bacterial entry into non-phagocytic cells upon 
interaction with their specific host cell surface receptors. While InlA interacts with 
only one receptor, the E-cadherin, InlB interacts with several other receptors 
among which hepatocyte growth factor receptor (c-Met) is the major representative 
(Mengaud et al. 1996, Braun et al. 2000, Shen et al. 2000, Jonquieres et al. 2001). 
The signaling cascades triggered downstream the InlA/E-cadherin and InlB/c-Met 
interactions, during Lm entry into host cells, have been characterized in detail 
(Bierne and Cossart 2002, Cossart et al. 2003, Sousa et al. 2004, Sousa et al. 
2005, Hamon et al. 2006, Sousa et al. 2007, Bonazzi et al. 2008, Pizarro-Cerda et 
al. 2012). 
c-Met belongs to the family of RTKs, an important family of transmembrane 
signaling receptors, expressed in a variety of cells. Upon stimulation by InlB, c-Met 
phosphorylation takes place, together with phosphorylation of Cbl, Shc and Gab1 
(Ireton et al. 1996, Shen et al. 2000). The recruitment and activation of Gab1 
promoted by InlB can take place through two redundant pathways, both of which 
require either phosphorylation of c-Met tyrosine residues and Gab1 binding to the 
activated c-Met multi-docking site, or activation of PI3K, leading to recruitment of 
phosphatidylinositol triphosphate (PIP3) and Gab1 (Basar et al. 2005). Gab1, Shc 
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and Cbl are also involved in the activation of PI3K (Ireton et al. 1996), which in 
turn is involved in activation of the small GTP-binding protein Rac1 and induction 
of actin polymerization through the activity of WAVE and Arp2/3 complex for 
membrane remodeling and bacterial internalization (Figure 9) (Bierne et al. 2005).  
 
 
Figure 9. Schematic representation of the host factors that mediate the InlB/c-Met-
dependent Lm uptake. 
 
The structure of InlB and its labile association to the cell wall of Lm allows 
the bacteria to express this internalin in both Lm-bound and soluble forms. The 
interaction between Lm-bound and soluble InlB with c-Met induces strong actin 
polymerization at the site of bacterial attachment. Moreover the stimulation of c-
Met by soluble InlB promotes a spread membrane ruffling and further cell 
scattering (Shen et al. 2000).  
PIP2 and PIP3 are two plasma membrane phosphoinositide species that 
function as modulators of actin dynamics during Lm invasion. The InlB/c-Met 
interaction is also responsible for the production of phosphatidylinositol 4-
phosphate (PIP4) by PI-4 kinases, which are activated in a PI3K-independent 
mechanism of host cell invasion by Lm (Pizarro-Cerda et al. 2007). Besides lipid 
kinases, host lipid phosphatase OCRL dephosphorylates PIP2 and PIP3. 
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Moreover, OCRL phosphatase activity at the plasma membrane restricts Lm 
invasion by altering actin dynamics at bacterial entry sites (Kuhbacher et al. 2012).  
During InlA/E-cadherin-mediated entry, Src, a non-receptor tyrosine kinase 
is activated. Cortactin, a Src substrate is immediately recruited and the Arp2/3 
complex is in turn activated. In addition, the small GTPase Rac1 is also required 
for this process (Sousa et al. 2007). These data suggest a model in which 
activated Src kinase, together with Rac1, promotes recruitment and 
phosphorylation of cortactin and activation of Arp2/3 complex at the bacterial entry 
site, where active actin polymerization takes place. Subsequentially, it has been 
shown that InlA triggers two successive E-cadherin post-translational 
modifications: Src-mediated tyrosine phosphorylation and ubiquitination by the 
ubiquitin ligase Hakai (Figure 10) (Bonazzi et al. 2008).  
Several studies have demonstrated that Lm entry into cells involves the 
clathrin-dependent endocytic machinery (Veiga and Cossart 2005, Veiga et al. 
2007). Moreover, both InlA and InlB trigger clathrin tyrosine phosphorylation that is 
required for bacterial internalization (Bonazzi et al. 2011). 
As mentioned before, bacterial effectors directly or indirectly induce host 
protein phosphorylation. Interestingly, these effectors can be themselves post-
translationally modified. In the context of Lm infection, studies have revealed that 
some virulence factors can be phosphorylated either by bacterial kinases (e.g. Lm 
activates its superoxide dismutase through phosphorylation, enabling its protective 
 
Figure 10. Schematic representation of the host factors that mediate InlA/E-cadherin-
dependent Lm uptake. 
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role against reactive oxygen species produced by the host innate immune system 
(Archambaud et al. 2006)) or by host kinases. Examples of the latter case include 
the phosphorylation of LLO, to prevent its pore-forming activity to cause further 
host cell damage, and of ActA, to mimic the actin nucleation-promoting activity of 
host cell proteins (Schnupf et al. 2006, Chong et al. 2009). 
 
II.A.2. Protein phosphorylation in other bacterial infections 
 
Several studies have demonstrated the importance of phosphorylation 
signaling events in the establishment of infections. Some examples will be 
presented in more detail. 
The effector YpkA produced by Yersinia spp. has structural and functional 
similarities to serine/threonine kinases. This effector is autophosphorylated and 
activated in the host cell, where it disrupts the actin-based cytoskeletal system 
(Barz et al. 2000, Dukuzumuremyi et al. 2000, Juris et al. 2000, Prehna et al. 
2006, Wiley et al. 2009, Edelmann et al. 2010, Pha et al. 2014). Host kinase Hri 
(elF2α kinase) is highly phosphorylated by YpkA and this event was shown to play 
a protective role against YpkA-derived cell toxicity (Wiley et al. 2009). YopM, 
another Yersinia effector, has been shown to simultaneously bind to and activate 
two host protein kinases, protein kinase C-like 2 (PRK2) and ribosomal S6 protein 
kinase 1 (RSK1) (McDonald et al. 2003, Hentschke et al. 2010). As mentioned, to 
promote invasion, Yersinia induces the activation of several other host kinases, 
such as FAK, Src and PI3K (Alrutz and Isberg 1998, Cossart and Sansonetti 
2004). 
As previously mentioned, EPEC and EHEC make use of a TTSS for the 
delivery of effector molecules to generate actin- and keratin-rich pedestals 
beneath adherent bacteria (Patel et al. 2006). During this process, the intimin 
receptor (Tir) translocates into host cell and inserts into the plasma membrane. Tir 
becomes phosphorylated on tyrosine residues by host kinases Fyn, Abl and PKA, 
leading to the generation of actin filaments beneath the attached bacteria and the 
consequent formation of the pedestal structure (Gruenheid et al. 2001, Backert et 
al. 2008, Brandt et al. 2009). EPEC and EHEC actin pedestals rely on Tir 
phosphorylation as an upstream command signal for the actin polymerization 
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machinery (Nieto-Pelegrin and Martinez-Quiles 2009, Vingadassalom et al. 2009, 
Crepin et al. 2010, Vingadassalom et al. 2010). Recent studies demonstrated that 
the secreted effector EspZ augments FAK and AKT phosphorylation, contributing 
to cytotoxicity protection (Shames et al. 2010). Furthermore, these extracellular 
pathogens appear to block bacterial uptake by a mechanism dependent on 
caveolin-1 tyrosine phosphorylation (Boettcher et al. 2010). 
Both Salmonella and Shigella interact with host cells by a TTSS that 
delivers bacterial effectors directly into the host cytoplasm, in subdomains 
enriched in signaling molecules, such as tyrosine kinases of the Src family 
(Cossart and Sansonetti 2004). SopB, a Salmonella TTSS effector, functions as a 
phosphoinositide phosphatase that catalyzes the dephosphorylation of host 
phosphatidylinositol species, stimulating actin rearrangements (Norris et al. 1998, 
Terebiznik et al. 2002). SptP, another Salmonella TTSS-secreted protein, has two 
functions: as a tyrosine phosphatase, it regulates MAPK activity induced by 
bacterial internalization; and as a GAP, it controls the activity of Cdc42 and Rac, 
resulting in the shrinking of the entry focus by blocking further actin polymerization 
(Stebbins and Galan 2000). Recently, SteA has been shown to control SCV 
membrane dynamics (Domingues et al. 2014). Constitutive expression in HeLa 
cells lead to the induction of genes related to host cell processes associated with 
serine/threonine kinase signaling pathways (Cardenal-Munoz et al. 2014).  
In Shigella infection activation of c-Src is followed by cortactin tyrosine 
phosphorylation and its recruitment to the cell membrane. Moreover, IpaC induces 
the activation of GTPases Cdc42 and Rac1, altogether these signaling events lead 
to massive actin polymerization at the vicinity of the bacterial entry site (Dehio et 
al. 1995, Adam et al. 1996, Tran Van Nhieu et al. 1999). The Abl family of tyrosine 
kinases is also involved in Shigella entry through phosphorylation of the adaptor 
molecule Crk (Bougneres et al. 2004, Backert et al. 2008, Vepachedu et al. 2009). 
The Shigella outer protein OspF induces apoptosis of DCs by binding and 
dephosphorylating phospho-Erk (Kim et al. 2008). Moreover, upon interaction with 
ILK, OspE decreases FAK and paxilin phosphorylation as a way to prevent 
bacterial-cell detachment (Kim et al. 2009). Recently, it has been described that 
Shigella actin-based motility inside intestinal epithelial cells is regulated by the 
host Bruton's tyrosine kinase (Btk). Btk inhibition effectively impaired Shigella 
spread from cell to cell (Dragoi and Agaisse 2014).  
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Rickettsia conorii recruits the Arp2/3 complex to the site of entry and its 
invasion is dependent on PI3K and Src-family kinases. In fact, c-Src and its 
downstream target, cortactin, colocalize at entry sites. R. conorii internalization 
correlated with the tyrosine phosphorylation of several other host proteins, 
including FAK (Martinez and Cossart 2004). 
Through a type four secretion system (T4SS), Helicobacter pylori (H. pylori) 
translocates into the host cytoplasm one of its main virulence factors, CagA, which 
modulates cellular functions related to cytoskeleton, cell-to-cell adhesion and 
intracellular signal transduction (Hayashi et al. 2012, Kaplan-Turkoz et al. 2012, 
Mueller et al. 2012). Once inside the host cell, CagA interacts with host tyrosine 
kinases, becoming tyrosine-phosphorylated by the action of kinases from the Src 
and Abl family. After phosphorylation by c-Src and Fyn, CagA remains at the 
plasma membrane, where it interacts with a number of proteins and triggers 
signals resembling the activation of the RTKs such as c-Met (Amieva and El-Omar 
2008, Backert and Selbach 2008, Franke et al. 2008). Recently, the CagA 
phosphorylation status has been shown to mediate SHP2/ERK and JAK/STAT3 
pathway balance during infection of epithelial cells (Lee et al. 2010). H. pylori 
stimulates an inflammatory response by phosphorylating IκBα, which is counter-
regulated by the interference of Muc1 cell receptor with the IKKγ in IKK→ 
IκBα→NFκB activation pathway (Guang et al. 2010). Integrin-linked kinase (ILK) is 
involved in an alternative inflammatory signaling pathway in response to 
lipopolysaccharide (LPS), causing activation of NF-κB and phosphorylation of p65 
at the S536 residue. This alternative activation through S536 phosphorylation also 
occurs during H. pylori infection of macrophages and gastric cells. ILK-mediated 
phosphorylation of p65 is dependent on the PI3K/Akt pathway during H. pylori-
induced inflammatory response (Ahmed et al. 2014). 
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III. MYOSINS 
 
The intracellular architecture is supported by an interconnected network of 
filaments that confer morphological organization and stability to the cell during 
processes such as movement and division. The eukaryotic cytoskeleton comprises 
actomyosin filaments, microtubules and intermediate filaments (Hartman and 
Spudich 2012).  
To properly exert their multiple physiological functions, some cellular 
components must be anchored to pre-existing molecular framework structures. 
Intracellular transport leads to physiological asymmetries both in cell morphology 
and macromolecular complexes composition. For long-range transportation, cells 
take advantage of motor proteins that convert the energy of ATP hydrolysis into 
mechanical work known as myosins (O'Connell et al. 2007). 
Structural and functional studies of the actomyosin cytoskeleton were first 
focused on actin (Conti and Adelstein 2008), until the myosin protein family was 
characterized, in particular the non-muscle myosin II subfamily (Kuhne 1860). 
 
III.A. Structure, classification and function 
 
Myosins are actin-based molecular motors that contribute to cellular 
organization in a variety of ways (O'Connell et al. 2007). Typically, myosins are 
composed by a pair of heterotrimeric protein complexes, each consisting of a 230-
kDa myosin heavy chain (MHC), a regulatory light chain (RLC) that modulates the 
myosin motor activity, and an essential light chain (ELC) that stabilizes myosin 
structure. The MHC contains three domains: (i) the N-terminal head or motor 
domain, responsible for actin binding and conversion of ATP energy into 
mechanical force; (ii) a hinged neck region containing one or more isoleucine-
glutamine (IQ) motifs; and (iii) a C-terminal tail domain (Figure 11) (Sellers 2000, 
Berg et al. 2001, Krendel and Mooseker 2005, O'Connell et al. 2007). The neck 
regions are stabilized by the binding of the light chains, which allows these regions 
to swing like a lever arm (Howard 1997). Besides providing a certain degree of 
rigidity to the neck regions, the RLC also participate in the regulation of the 
ATPase and motor activities of the MHC component. Regulatory mechanisms of 
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RLC involve direct binding of calcium ions to the light chains or the post-
translational modification of the light chains by phosphorylation.  
 
Figure 11. Myosin domains and structure. (A) Schematic representation of the myosin heavy 
chain (MHC): N-terminal motor/head domain (actin binding and ATP hydrolysis sites); neck region 
containing isoleucine-glutamine (IQ) motifs and a C-terminal tail domain. (B) Schematic 
representation of the myosin heterohexameric structure. Typical myosins are composed by two 
heterotrimers of one MHC and two myosin light chains (one RLC and one ELC). Myosin light 
chains interact with the MHC neck domain.  
 
 Together with the neck or regulatory domain, the myosin head domain 
forms the motor region that is sufficient for mechanical force generation along 
actin filaments (Bahler 2000).  
The tail domain directs the interaction of a given myosin with its cargo and 
is responsible for class-specific properties and dimerization of MHCs. In addition, 
MHC tails also contain some conserved subdomains, which are responsible for 
protein-protein interactions in signaling cascades or additional functions, such as 
kinase activity or lipid binding (Lu et al. 2014). Several tail-binding proteins have 
been identified which have provided important insights into specific myosin 
functions. Functional diversity across myosins is also manifested by significant 
differences in the motor properties.  
Sequence analysis has allowed the identification of a large number of 
myosin sub-families (Odronitz and Kollmar 2007), although their classification is 
nowadays based more on the characterization of their biochemical and 
mechanical properties. Based on their motor properties, it has been proposed for 
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myosins to be classified into four different groups: (1) fast movers, (2) 
slow/efficient force holders, (3) strain sensors, and (4) gates (Bloemink and 
Geeves 2011). To date, the myosin superfamily consists of at least 37 different 
classes based on the sequence comparison of both myosin head and tail domain 
organization (Krendel and Mooseker 2005, Odronitz and Kollmar 2007, Conti and 
Adelstein 2008).  
 Myosins are fundamental for eukaryotic cell motility (Even-Ram et al. 2007), 
and also assume an important role in cytokinesis (class II myosins) and 
organelle/particle trafficking (classes I and V) (Thompson and Langford 2002). 
Myosins are also implicated in cell polarization (class V) (Yin et al. 2000) and 
intracellular signal transduction pathways (classes I, III, VI, VII and IX), in which 
they modulate the activity of other proteins and position signaling activities at the 
cytoskeleton-membrane interface (Bahler 1996, Bahler 2000). Additionally, 
myosins have been described to play important roles in cell migration (Vicente-
Manzanares et al. 2009), phagocytosis (classes II, IXb and X) (Groves et al. 
2008), growth cone extension and maintenance of cell shape (classes I and II) 
(Berg et al. 2001), and actin polymerization (class I), revealing the molecular basis 
of actin-based cell motility (Evangelista et al. 2000, Lechler et al. 2000, Lee et al. 
2000). Several human pathologies have been associated with mutations within 
myosin genes (Redowicz 2002). 
 
III.B. Non-muscle myosin IIA (NM-IIA) 
 
The myosin II subfamily was the first class of myosins to be described, 
being referred to as “conventional myosins”, with all other classes considered to 
be “unconventional” (Kalhammer and Bahler 2000, Billington et al. 2013). Myosin II 
members include both skeletal, cardiac and smooth muscle myosins, and non-
muscle myosin (NM-II). Typically, NM-II molecules by MHC interactions form 
bipolar filaments that bind through motor domain to actin cables that slide in an 
antiparallel mode. In an actin-dependent manner, NM-II converts chemical energy 
from ATP hydrolysis to mechanical energy required to generate movement on top 
of actin fibers (Conti and Adelstein 2008, Vicente-Manzanares et al. 2009, 
Hartman and Spudich 2012). 
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In mammals, NM-II heavy chains (NMHC-II) have three isoforms (NMHC-
IIA, NMHC-IIB and NMHC-IIC), each encoded by an independent gene (MYH9, 
MYH10 and MYH14, respectively). For this reason, the corresponding NM-II 
variants are accordingly named NM-IIA, NM-IIB and NM-IIC (Wang et al. 2011, 
Billington et al. 2013). The three NM-II isoforms exhibit 60-80% amino acid 
homology, which is higher between motor domains and lower between the non-
helical terminal tail sequence (Wang et al. 2011, Billington et al. 2013). Each 
isoform has a differential tissue/organ expression, function and distribution. 
Nevertheless, there is still some degree of functional and spatial redundancy, 
suggesting overlap of cellular functions (Maupin et al. 1994, Kelley et al. 1996, 
Kolega 1998, Bao et al. 2005, Vicente-Manzanares et al. 2007). 
The work presented on this thesis has focused mainly on NM-II isoform A 
(NM-IIA).  
 
III.B.1. NM-IIA structure 
 
Different cell types present different modes of NM-IIA activation, either 
through actin-associated proteins (troponin and tropomyosin), in the case of 
skeletal and cardiac muscle cells, or through phosphorylation of NM-IIA RLCs, as 
described in vertebrate non-muscle and smooth muscle cells (Adelstein and Conti 
1975, Amano et al. 1996, Kimura et al. 1996). 
NMHC-IIA displays the archetypal myosin heavy chain structure. It contains 
a globular head domain comprising both ATP- and actin-binding sites (Vicente-
Manzanares et al. 2009, Billington et al. 2013). This domain displays an actin-
dependent Mg2+-ATPase activity that converts ATP hydrolysis energy into 
mechanical force required for NM-IIA sliding on top of actin filaments (Billington et 
al. 2013). Following the head domain, an extended alpha-helical neck region that 
contains a variable number of calmodulin or calmodulin-like light chain-binding 
sites (Sweeney and Houdusse 2010). It acts as a lever arm that amplifies the head 
domain rotation, upon ATP hydrolysis (Vicente-Manzanares et al. 2009, Hartman 
and Spudich 2012). The neck region of NM-IIA binds very tightly, although not 
covalently, two RLCs and two ELCs.  
The cellular role and localization of a particular myosin are encoded in the 
tail domain. In the case of NM-IIA, it was shown that the C-terminal 179-190 amino 
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acid residues determine its intracellular location (Bao et al. 2005, Vicente-
Manzanares et al. 2007). The NM-IIA C-terminal domain is a long (1100 amino 
acids) α-helical region that is responsible for the antiparallel MHC dimerization in 
NM-II molecules. This bipolar filament formation confers the capacity to cross-link 
distinct actin filaments and exert tension (Wang et al. 2011, Billington et al. 2013). 
 
III.B.2. Regulation of NM-IIA activity 
 
NM-IIA regulation is different from other myosins and also varies from lower 
to higher eukaryotes (Somlyo and Somlyo 2003, Heissler and Manstein 2013). 
The RLCs regulate the Mg2+-ATPase activity and are important for myosin filament 
dimerization, in a process that requires RLC phosphorylation, particularly on Thr18 
and Ser19 residues (Vicente-Manzanares et al. 2009, Wang et al. 2011, Heissler 
and Manstein 2013). Two particular kinases, Rho-associated kinase (ROCK) and 
myosin light chain kinase (MLCK) have been described to phosphorylate NM-IIA 
RLCs (Figure 12) (Kamm and Stull 2001, Matsumura 2005, Sandquist et al. 2006).  
 
NM-IIA filament assembly is also regulated by phosphorylation of MHCs 
coiled-coil and tail domains. Phosphorylations occur at thr1800, ser1803 and 
ser1808 by transient receptor potential melastatin 7 (TRPM7) (Clark et al. 2008), 
at ser1916 by PKCβ (Conti et al. 1991, Ludowyke et al. 2006) and at ser1943 by 
 
Figure 12. Schematic diagram of myosin motor activation by RLC phosphorylation. Myosin 
activation requires phosphorylation of its regulatory light chain (RLC) by the myosin light chain 
kinase (MLCK) or by the Rho-associated kinase (ROCK). Dephosphorylation of RLC is catalyzed 
by the myosin light chain phosphatase (MLCPase). Various inhibitors interfere with myosin 
activation: ROCK is inhibited by Y-27632 and MLCK is inhibited by ML-7 or ML-9. Adapted from 
(Fabian et al. 2007). 
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casein kinase II (CK II) (Dulyaninova et al. 2005, Li and Bresnick 2006). In each 
case phosphorylation of the MHC compromises myosin filament assembly or 
stability interfering with cell motility.  
 
III.B.3. Cellular functions of NM-IIA 
 
 NM-IIA has been associated to different cell processes, based on its 
canonical protein function. It has been demonstrated that NM-IIA has an essential 
role in cell polarization during mitosis (Conti and Adelstein 2008), and cell 
migration studies implicate this isoform in membrane protrusion activity (Even-
Ram et al. 2007, Vicente-Manzanares et al. 2007). Cell-to-cell adhesions and 
contractile activity were also shown to require NM-IIA activation (Vicente-
Manzanares et al. 2007, Vicente-Manzanares et al. 2009, Smutny et al. 2010).  
During cytokinesis, NM-IIA binds to actin filaments to generate the force 
and tension required at the constriction ring (Guha et al. 2005). NM-IIA functions 
are strongly related to cell membrane tension and reshape. Other studies have 
been consistently describing NM-IIA role in vesicle trafficking and membrane 
repair (Togo and Steinhardt 2004, Lin et al. 2012, Petrosyan et al. 2012). 
Moreover, actomyosin function in mitochondrial DNA (mtDNA) maintenance and 
transmission has been shown implicate interactions of mtDNA with NM-IIA. NM-IIA 
in this study was present at mitochondrial nucleoprotein complexes (Reyes et al. 
2011). 
 
III.C. Myosins and bacterial infection 
 
Myosins are among the host cytoskeleton proteins hijacked by bacterial 
pathogens during infection.  
 Neisseria gonorrhoeae infection of mucosal epithelial tissues involves 
bacterial adherence to the host cell, followed by invasion, trans-epithelial 
trafficking and, finally, exocytosis. Host cell factors, necessary for gonococcal 
adherence, entry and transcytosis include membrane receptors that interact with 
neisserial opacity-associated (Opa) proteins (Wang et al. 1998). However, 
rearrangements of the host cytoskeleton are also required for the success of 
Neisseria infection (Pujol et al. 2000, Wang et al. 2008). It has been shown that 
 53 
myosin I is involved in Neisseria invasion and transcytosis, but not in adherence. It 
was also suggested that cell invasion by Opa-expressing gonococci may be driven 
by myosin I molecules sliding along actin filaments to the basal side of the 
epithelium (Wang et al. 2008). However, the molecular basis of myosin I function 
in the alterations of the cytoskeleton upon Neisseria infection is not yet completely 
understood.  
 Shigella flexineri was found to disseminate through the intestinal epithelium 
via protrusions that extend from infected cells and are engulfed by neighboring 
cells (Rathman et al. 2000). It has been shown that phosphorylation of myosin II 
by its upstream regulator, MLCK, leads to the formation of the bacterium-
containing protrusion and can also contribute to its engulfment by adjacent cells 
(Rathman et al. 2000). The myosin IXb has been identified as a regulator of 
Shigella infection, being recruited to Shigella-induced cellular projections essential 
for bacterial entry. Myosin IXb has a GAP subdomain in its tail domain that, 
together with its actin-binding site, establishes a connection between Rho-like 
GTPases and the cytoskeleton. Shigella invasion efficiency is probably a result of 
tightly regulated Rho-dependent cytoskeletal rearrangements, underlining the 
sophisticated use of the motor and GAP activities of a class IX myosin by Shigella, 
during infection of epithelial cells (Graf et al. 2000). 
 Previous studies suggested that myosins have a role in the dynamics of 
Salmonella-containing vacuoles (SCVs) within infected host cells. Furthermore, 
vacuole positioning is controlled by specific bacterial effectors, through the 
activation of myosin II (Wasylnka et al. 2008). Salmonella invasion has also been 
shown to be a myosin II-mediated process complementary to the Arp2/3-
dependent pathway. The TTSS effector SopB is implicated in the regulation of this 
myosin II-dependent invasion pathway (Hanisch et al. 2011). Salmonella persists 
and replicates in SCVs, which recruit and accumulate F-actin through the kinase 
activity of the SPI-2 effector SteC. It has recently been described that SteC 
promotes actin rearrangements by activating a signaling pathway involving the 
MAP kinases MEK and ERK, MLCK and NM-IIB (Odendall et al. 2012).  
 EPEC destroys intestinal microvilli and suppresses phagocytosis by 
injecting TTSS effectors into infected target cells. One of these effectors, EspB, 
was shown to bind to host myosins, and recent studies have identified myosin Ic 
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as one of these EspB-binding myosins. By binding to myosin Ic, EspB inhibits its 
interaction with actin, thus suggesting that EspB inhibits actomyosin-associated 
processes, which facilitates efficient EPEC infection (Iizumi et al. 2007). 
  
 
Previous work by Sousa and colleagues enabled the identification of two 
novel host proteins involved in Lm-induced uptake by host cells: myosin VIIa 
(unconventional myosin) and its ligand vezatin. Vezatin is a transmembrane 
protein that binds to myosin VIIa and recruits it to adherens junctions (Kussel-
Andermann et al. 2000). Both proteins are recruited to the Lm entry site, where 
they localize with actin, suggesting that vezatin acts as the molecular link between 
myosin VIIa and the E-cadherin/catenins/actin complex (Figure 10). It was also 
demonstrated that myosin VIIa is required for InlA/E-cadherin-mediated 
internalization, but not for entry mediated by the other Lm invasin, InlB (Sousa et 
al. 2004). Another unconventional myosin, myosin VI, is recruited to the fully 
assembled clathrin-actin machinery complex located at the Lm entry site, where it 
likely plays a role in generating the pulling force required for bacterial 
internalization (Bonazzi et al. 2011). 
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Infectious diseases are major threats to human health worldwide, and 
tremendous effort has gone into understanding various infectious agents and their 
mechanisms of virulence. In particular, the mechanism through which invasive 
bacteria exploit mammalian host cell components to induce their entry into cells 
has received special attention in the last two decades. Model organisms have 
emerged and helped understanding the various mechanisms that are used. 
Among those, Lm is one of the most documented. Investigations on InlA- and InlB-
mediated entry pathways have repeatedly shown that Listeria fully usurps the host 
cell machinery. Moreover, they have also shown that unknown cellular 
components discovered during the study of Listeria invasion play a role either in E-
cadherin-mediated cell–cell adhesion or c-Met signaling. 
 Phosphorylation cascades have been extensively involved in cell signaling 
processes. Protein phosphorylation is an essential regulatory mechanism allowing 
the activation or deactivation of protein functions in response to an external 
stimulus. Importantly, phosphorylation events have been described as key 
regulators of cellular processes such as metabolic pathways, cell cycle, molecule 
transport and secretion, cytoskeleton organization and cell adhesion. The 
uncontrolled protein phosphorylation/dephosphorylation leads to cellular 
dysfunctions associated to serious diseases. 
 Given the central role of phosphorylation events in the normal cellular 
processes, the phosphorylation cascades are targeted by bacterial pathogens in 
order to hijack the host cell machinery. Lm, as other human pathogens, induces 
the phosphorylation of its cellular receptors and triggers a series of 
phosphorylation events that contribute to the bacterial internalization. At the time 
when I started my PhD, a recent publication from our laboratory showed that 
shortly after the incubation of Lm with epithelial cells Src kinase was activated. E-
cadherin-mediated Lm internalization required the small GTPase Rac1 and Src-
tyrosine kinase activity to recruit cortactin and activate Arp2/3 complex, regulating 
the transient actin polymerization required at the bacterial entry site. In this study, 
in response to Lm, the only Src kinase substrate identified to be phosphorylated, 
was cortactin (Sousa et al. 2007). Given that, the project of my PhD was focused 
in the identification of other potential targets of tyrosine phosphorylation and their 
role in Lm infection. I specifically focused on tyrosine phosphorylation cascades 
and searched for host cellular proteins showing a different tyrosine 
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phosphorylation status in infected as compared to non-infected cells. The role of 
identified proteins in the infectious process has been addressed. Moreover, I also 
aimed to investigate whether these tyrosine phosphorylations are important for 
bacterial pathogenesis and if they are dependent on already known pathogen 
virulence factors. The respective kinases that regulate the identified 
phosphorylation events were also part of the objectives of this study. In addition, 
the function of the phosphorylated residues in the identified proteins was important 
to determine the significance of such post-translational modification in both 
infection and normal cell biology processes, as well as their integration in 
contextualized signaling pathways. Given that different pathogens often hijack the 
same eukaryotic pathways, I intend to investigate whether the identified proteins 
were specifically targeted during Lm infection or exploited by other human 
pathogens. Although Lm was the pathogen model, in collaboration studies, I would 
also study the identified signaling events in Yersinia and pathogenic E. coli (EPEC 
and EHEC) infection. Globally my PhD project aimed to reveal new host 
intracellular pathways that are exploited by the pathogens in order to cause and 
establish infection. 
  
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
Note: This chapter is divided in three sections. The results presented in section I 
correspond to the work developed as the main research line of this PhD project 
and published at Journal of Biological Chemistry (J. Biol. Chem. 2015 290: 8383-
8395. First Published on January 29, 2015). Sections II and III correspond to the 
results obtained in complementary projects in which I participated. 
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Background: Non-muscle myosin IIA is involved in force generation, movement and membrane 
reshaping. Its activity is regulated by phosphorylation of the light chain. 
Results: NMHC-IIA head domain is tyrosine phosphorylated by Src and modulates Listeria 
intracellular levels. 
Conclusion: Tyrosine phosphorylation of NMHC-IIA affects the outcome of infection.  
Significance: This novel post-translational modification of NMHC-IIA possibly affects its functions. 
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SUMMARY 
 
Bacterial pathogens often interfere with host tyrosine phosphorylation 
cascades to control host responses and cause infection. Given the role of tyrosine 
phosphorylation events in different human infections and our previous results 
showing the activation of the tyrosine kinase Src upon incubation of cells with 
Listeria monocytogenes (Lm), we searched for novel host proteins undergoing 
tyrosine phosphorylation upon Lm infection. We identify the heavy chain of the 
non-muscle myosin IIA (NMHC-IIA) as being phosphorylated in a specific tyrosine 
residue in response to Lm infection. We characterize this novel post-translational 
modification event and show that, upon Lm infection, Src phosphorylates NMHC-
IIA in a previously uncharacterized tyrosine residue (Y158) located in its motor 
domain near the ATP-binding site. In addition, we found that other intracellular and 
extracellular bacterial pathogens trigger NMHC-IIA tyrosine phosphorylation. We 
demonstrate that NMHC-IIA limits intracellular levels of Lm and this is dependent 
on the phosphorylation of Y158. Our data suggest a novel mechanism of 
regulation of NMHC-IIA activity relying on the phosphorylation of Y158 by Src. 
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INTRODUCTION 
 
Listeria monocytogenes (Lm) is a human intracellular foodborne bacterial 
pathogen that causes serious disease in immunocompromised individuals. Within 
the host it finds suitable replication niches in the liver and spleen, disseminates 
and can reach the central nervous system. In pregnant women, Lm targets the 
fetus, eliciting fetal infection and abortions (Allerberger and Wagner 2010). The 
ability of Lm to cause disease relies on its capacity to invade nonphagocytic cells, 
replicate therein and spread to the entire organism overcoming the intestinal, 
blood-brain and fetoplacental barriers (Lecuit 2005). Through the expression of 
bacterial factors Lm establishes a crosstalk with host cells favoring the progression 
of the cellular infection (Camejo et al. 2011). In epithelial cells, Lm invasion is 
mainly driven by the bacterial surface proteins InlA and InlB that bind E-cadherin 
and c-Met, respectively, at the surface of host cells (Mengaud et al. 1996, Shen et 
al. 2000). This engagement of host cell receptors triggers tyrosine 
phosphorylation-mediated signaling, resulting in the local activation of the Arp2/3 
complex that initiates actin polymerization at the site of Lm attachment (Bierne et 
al. 2001, Sousa et al. 2007), causing membrane invagination that supports 
bacterial entry. InlB interaction with the receptor tyrosine kinase c-Met stimulates 
its auto-phosphorylation, induces the tyrosine phosphorylation and recruitment of 
adaptor proteins, and the activation of phosphoinositide 3-kinase (PI3K) (Ireton et 
al. 1996, Ireton et al. 1999, Shen et al. 2000). Phosphatidylinositol (3,4,5)-
triphosphate generated by PI3K accumulates at the cell membrane during Lm 
infection (Ireton et al. 1996) and plays a crucial role in the recruitment of molecules 
controlling actin polymerization, such as Rac1 and WAVE2 (Bierne et al. 2001, 
Seveau et al. 2004, Bierne et al. 2005, Kuhbacher et al. 2012). In turn, InlA binding 
to E-cadherin induces the activation of Src tyrosine kinase that subsequently 
phosphorylates cortactin, E-cadherin and the clathrin heavy chain (Sousa et al. 
2007, Bonazzi et al. 2008, Bonazzi et al. 2011). While cortactin and clathrin 
tyrosine phosphorylations are critical events for actin polymerization and 
recruitment at the Lm entry site (Sousa et al. 2007, Bonazzi et al. 2011), E-
cadherin phosphorylation leads to its ubiquitination, internalization and further 
degradation (Bonazzi et al. 2008). The combined action of these events leads to 
the internalization the Lm into epithelial cells.  
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In this study we aimed to identify new cellular proteins undergoing tyrosine 
phosphorylation in response to Lm infection and address whether such post-
translational modification would regulate cellular infection. The tyrosine 
phosphorylated proteins were recovered from Lm-infected epithelial cells and 
subjected to mass spectrometry identification. We identified the non-muscle 
myosin heavy chain IIA (NMHC-IIA) as one of the enriched tyrosine 
phosphorylated proteins recovered upon Lm infection. 
NMHC-IIA is an actin-binding protein with motor and contractile properties, 
involved in cellular processes requiring force generation, cell movement and 
membrane reshaping (Vicente-Manzanares et al. 2009). In infection, NMHC-IIA is 
critical for viral entry (Arii et al. 2010, Valiya Veettil et al. 2010) and supports 
invasion (Hanisch et al. 2011) and dissemination (Hybiske and Stephens 2007) of 
various bacteria. While the serine/threonine phosphorylation of the regulatory light 
chain is a well-known mechanism to regulate non-muscle myosin IIA activity 
(Vicente-Manzanares et al. 2009), our knowledge on the regulation of the heavy 
chain is limited and NMHC-IIA tyrosine phosphorylation has never been 
characterized. Here we show that NMHC-IIA undergoes tyrosine phosphorylation 
in response to several bacterial pathogens. Our data indicate that upon Lm cellular 
infection NMHC-IIA was phosphorylated in tyrosine residue 158 by the host Src 
kinase. In the presence of blebbistatin, a chemical inhibitor of Myosin II activity, the 
percentage of cells showing Lm-associated actin foci was increased and 
correlated with higher levels of intracellular Lm. In addition, increased numbers of 
intracellular Lm were also found in cells depleted for NMHC-IIA as well as in 
conditions where NMHC-IIA tyrosine phosphorylation is prevented. These results 
show the involvement of NMHC-IIA in Lm infection and point to the regulatory role 
of its phosphorylation in tyrosine 158 which could affect NMHC-IIA activity. Our 
findings describe a novel post-translational modification of NMHC-IIA with 
important implications in bacterial infection. Taking into account the central role of 
NMHC-IIA in key cell biology processes, our data also suggest the existence of a 
new mechanism of NMHC-IIA regulation that could be of critical importance in the 
canonical functions of non-muscle Myosin IIA. 
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I. EXPERIMENTAL PROCEDURES 
 
Bacterial strains and cell lines. Listeria and E. coli strains were grown 
aerobically at 37 ºC, with shaking, in brain-heart infusion (BHI) and Lysogeny 
Broth (LB) media, respectively. Yersinia was grown aerobically at 26 ºC, with 
shaking, in LB media. When required antibiotics were added to growth media. 
Details are provided in Table 1. Caco-2 cells (ATCC HTB-37) were cultivated in 
MEM with L-glutamine, supplemented with non-essential amino acids, sodium 
pyruvate, and 20% fetal bovine serum (FBS). HeLa (ATCC CCL-2), HEK293 
(ATCC CRL-1573) and COS-7 (ATCC CRL-1651) cells were cultivated in DMEM 
with glucose (4.5 g/l) and L-glutamine, supplemented with 10% FBS. Cells were 
maintained at 37 ºC in a 5% CO2-enriched atmosphere. Cell culture media and 
supplements were from Lonza. 
 
 
 
 
 
Plasmids, antibodies and reagents. Plasmids used are listed in Table 2. 
Plasmids GFP-NMHC-IIA-Y158F and GFP-NMHC-IIA-Y190F were generated 
using GFP-NMHC-IIA-WT from Addgene (Wei and Adelstein 2000) and the 
QuickChangeII XL site-directed mutagenesis kit (Agilent Technologies). For 
NMHC-IIA rescue assays, a plasmid encoding siRNA-resistant GFP-NMHC-IIA-
 
 
 
 
 
Table 1. List of bacterial strains used in this study and the corresponding 
growth conditions. 
Bacterial strains Growth Media T (°C) 
L. monocytogenes (EGDe) BHI (Difco Laboratories) 37 
L. innocua (CLIP 11262) BHI 37 
L. innocua-inlB BHI Erythromycin 5µg/ml 37 
E. coli DH5α LB (Difco Laboratories) 37 
EPEC LB Ampicilin 100 µg/ml (Amp100) 37 
EHEC LB  37 
E. coli K12-inv LB Amp100 37 
E. coli K12-Δinv LB Amp100 37 
Y. pseudotuberculosis LB Amp100 26 
 
Table 2. List of plasmids used in this study. 
Plasmid Description Source 
GFP-NMHCIIA-WT pEGFP-C3:CMV-GFP-NMHC IIA Addgene (#11347) 
GFP-NMHCIIA-Y158F pEGFP-C3:CMV-GFP-NMHC IIA (Y158F) This study 
GFP-NMHCIIA-Y190F pEGFP-C3:CMV-GFP-NMHC IIA (Y190F) This study 
GFP-NMHCIIA-WT-
siRes pEGFP-C3:CMV-GFP-NMHC IIA siRNA resistant This study 
Src-KD pcDNA3-Src Kinase Dead (A430V) Sarah J. Parsons, Univ. of Virginia  
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WT transcripts was generated. Oligonucleotide sequences are provided in Table 
3. Antibodies are listed in Table 4. F-actin was labeled with Alexa Fluor 647- or 
555-conjugated phalloidin (Invitrogen). Chemical inhibitors Y-26732 (Sigma-
Aldrich), Blebbistatin and PP1 (Calbiochem) were handled as recommended. 
FluoSpheres-carboxylate modified microspheres were from Invitrogen (F-8814). 
 
 
 
Determination of intracellular bacteria. The levels of intracellular bacteria 
were determined as described (Reis et al. 2010). When indicated cells were 
incubated with serum-free medium containing blebbistatin, PP1 or DMSO. Cells 
were challenged with pre-washed Lm at a multiplicity of infection (MOI) of 50 or 
with Yp (MOI 10) for 60 min, treated with 20 µg/ml gentamicin for 90 min, washed 
in PBS, lysed with 0.2% Triton X-100 and serial dilutions were plated for CFU 
 
Table 3. Sequences of siRNA duplexes, shRNAs and primers used in this study. 
siRNA duplexes 
 Name Oligo Sequence (5’-3’) Source 
NMHCIIA-si#1 
(Pool of 3 
siRNAs) 
 
A 
Sense: CAUCUACUCUGAAGAGAUUtt 
Santa Cruz 
Biotechnology 
(#sc-61120) 
Antisense: AAUCUCUUCAGAGUAGAUGtt 
B 
Sense: GAAGAUCAAUCCAUCUUGUtt 
Antisense: ACAAGAUGGAUUGAUCUUCtt 
C 
Sense: CCAAAGAGAACGAGAAGAAtt 
Antisense: UUCUUCUCGUUCUCUUUGGtt 
NMHCIIA-si#2 
Sense: GAAGAUCAAUCCAUCUUGUtt Santa Cruz 
Biotechnology 
(#sc-61120B) Antisense: ACAAGAUGGAUUGAUCUUCtt 
NMHCIIB-si 
Sense: GCAAUACAGUGGGACAGUUtt Sigma-Aldrich 
(#00072460) Antisense: AACUGUCCCACUGUAUUGCtt 
shRNAs Sequence (5’-3’) and Source 
Src 
CCGGGTGGCTTACTACTCCAAACATCTCGAGATGTTTGGAGTAGTAAGCCACT
TTTT 
Sigma-Aldrich (TRCN0000023597) 
Control 
CCGGGCGCGATAGCGCTAATAATTTCTCGAGAAATTATTAGCGCTATCGCGCT
TTTT 
Sigma-Aldrich (SHC016) 
Primers sequences (5’-3’) 
NMHC-IIA-
Y158F 
Fw: CTATGCCATCACAGACACCGCCTTCAGGAGTATGATGCAAGAC 
Rev: GTCTTGCATCATACTCCTGAAGGCGGTGTCTGTGATGGCATAG 
NMHC-IIA-
Y190F 
Fw: CACCAAGAAGGTCATCCAGTTTCTGGCGTACGTGGCGTCTCG 
Rev: CGAGGACGCCACGTACGCCAGAACTGGATGACCTTCTTGGTG 
NMHC-IIA-WT-
siRes 
Fw: GATGCAAGACCGAGAGGATCAATCCATACTGTGCACTGGTGAATC 
Rev: GATTCACCAGTGCACAGTATGGATTGATCCTCTCGGTCTTGCATC 
c-Src 
Fw: CTGTTCGGAGGCTTCAACTC 
Rev: CCACCAGTCTCCCTCTGTGT 
HPRT1 
Fw: GGCGTCGTGATTAGTGATG 
Rev: CACCCTTTCCAAATCCTCAG 
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counting. For immunofluorescence scoring, cells infected with Lm (MOI 50) were 
treated with 100 µg/ml gentamicin for 10 min, and washed with 20 µg/ml 
gentamicin prior fixation. 
 
 
 
Immunoprecipitation assays. HeLa or Caco-2 cells grown until confluence 
were washed twice with warm phosphate-buffered saline (PBS), serum-starved (5 
h) and left non-infected (NI) or incubated with pre-washed Lm (Reis et al. 2010) at 
MOI 200 for different periods of time, or with E. coli (EPEC, EHEC or K12-inv 
strains) at MOI 200 for 4 h as described (Campellone et al. 2007). When indicated, 
cells were treated with 10 µM PP1 or 50 µM Y-27632 30 min before infection. After 
washing twice with ice-cold PBS, cells were lysed in 1 ml of lysis buffer [1% Igepal 
CA-630 (Sigma-Aldrich), 50 mM Tris pH 7.5, 150 mM NaCl, 2 mM EDTA, 1 mM 
AEBSF (Interchim), PhosSTOP and cOmplete Protease Inhibitor Cocktail (Roche 
Pharmaceuticals)] and lysates recovered after centrifugation (15,000 × g, 15 min, 
4 ºC). Cell lysates (500 µg) were incubated overnight (4 ºC) with 1 µg of anti-
phosphotyrosine 4G10 or 5 µg of anti-NMHC-IIA antibodies. Immune complexes 
were captured with 50 µl of PureProteome Protein A or G magnetic beads 
(Millipore). Immunoprecipitated fractions were resolved by SDS-PAGE and gels 
were silver-stained using the ProteoSilverTM Plus Silver Staining Kit (Sigma-
Aldrich) or processed for immunoblotting. For kinase assay, HEK293 cells were 
Table 4. List of antibodies used in this study. 
Antigen Species Applications Reference Source 
Phosphotyrosine Mouse IP (1:300) WB (1:1000) 4G10, 05-321 Millipore 
Phosphotyrosine Mouse WB (1:1000) PY20, P4110 Sigma-Aldrich 
Actin Mouse WB (1:5000) AC-15, A5441 Sigma-Aldrich 
NMHC-IIA Mouse IF (1:1000) ab55456 Abcam 
GFP Mouse IP (1:100) WB (1:500) B2, sc-9996 
Santa Cruz 
Biotechnology 
NMHC-IIA pY158 Rabbit WB (1:500) AP3775a Abgent 
Listeria Rabbit IF (1:200) ab35132 Abcam 
NMHC-IIA Rabbit IP (1:100) WB (1:5000) M8064 Sigma-Aldrich 
c-Src Rabbit WB (1:500) GD11, 05-184 Millipore 
c-Src Rabbit WB (1:1000) ab109381 Abcam 
NMHC-IIB Rabbit WB (1:1000) M7939 Sigma-Aldrich 
Anti-rabbit or anti-
mouse HRP Goat WB 
BI2413C 
BI2407 PARIS 
Anti-rabbit or anti-
mouse Alexa Fluor 
488 
Goat IF A11034 A11001 Invitrogen 
Anti-rabbit or anti-
mouse Cy3 Goat IF 
111-165-144 
115-165-146 
Jackson 
ImmunoResearch 
Anti-rabbit or anti-
mouse Cy5 Goat IF 
111-175-144 
115-175-146 
Jackson 
ImmunoResearch 
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harvested and lysed 24 h post-transfection, GFP fusion proteins were 
immunoprecipitated with anti-GFP conjugated agarose beads (sc-9996 AC, Santa 
Cruz Biotechnology) and eluted in 0.2 M glycine, pH 2.5. 
Protein identification by mass spectrometry (MS). Protein identification 
was performed by MALDI TOF/TOF mass spectrometry as described (Osorio and 
Reis 2013). Protein bands were excised from SDS-PAGE gels, reduced with 
dithiothreitol, alkylated with iodacetamide and in gel digested with trypsin. Peptides 
were extracted, desalted, concentrated using ZipTips (Millipore), crystallized onto 
a MALDI sample plate and analyzed using a 4700 Proteomics Analyzer MALDI-
TOF/TOF (Applied Biosystems). Peptidic mass spectra were acquired in reflector 
positive mode at a 700-4000 m/z mass window and proteins identified by Peptide 
Mass Fingerprint using the Mascot software (Matrix Science, UK) integrated in the 
GPS Explorer software (ABSCIEX, CA) and searched against the 
SwissProt/UniProt Homo sapiens protein sequence database. The maximum error 
tolerance was 35 ppm and up to two missed cleavages were allowed. 
Phosphopeptide analysis by MS. Bands corresponding to NMHC-IIA, from 
anti-NMHC-IIA IPs of NI and Lm-infected HeLa cells, were processed as described 
above. Phosphopeptides were selectively enriched by titanium dioxide 
chromatography (TiO2 Mag Sepharose, GE Healthcare). MALDI matrix used was 
THAP/DAC (2’,4’,6’-trihydroxyacetophenone monohydrate 9 mg/mL, diammonium 
citrate 5 mg/mL, in water/Acetonitrile 50:50, v/v). Mass spectra were acquired in a 
4800 Plus MALDI TOF/TOF Analyzer mass spectrometer (AB SCIEX) both in 
reflector negative and MS/MS modes. 
Immunoblotting. Proteins were resolved in SDS-PAGE gels and transferred 
onto Nitrocellulose membranes (Hybond ECL, GE Healthcare Life Sciences). 
Membranes were blocked with 5% skimmed milk in buffer A (150 mM NaCl, 20 
mM Tris-HCl pH 7.4 and 0.1% Triton X-100) for 1 h at room temperature or 
overnight at 4ºC. Primary and secondary antibodies were diluted in 2.5% skimmed 
milk in buffer A. Membranes used for anti-phosphotyrosine detection were blocked 
with Western Blocker solution (Sigma Aldrich), also used to dilute primary and 
secondary antibodies. 
Immunofluorescence analysis. Cells were fixed in 3% paraformaldehyde (15 
min), quenched with 20 mM NH4Cl (1 h), permeabilized with 0.1% Triton X-100 (5 
min) and blocked with 1% BSA in PBS (30 min). Antibodies were diluted in PBS 
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containing 1% BSA. Coverslips were incubated 1 h with primary antibodies 
washed three times in PBS and incubated 45 min with secondary antibodies and 
Phalloidin Alexa-555 or 647. DNA was counterstained with DAPI (Sigma-Aldrich). 
Coverslips were mounted onto microscope slides with Aqua-Poly/Mount (18606, 
Polysciences). Images were collected with a confocal laser-scanning microscope 
(Zeiss Axiovert LSM 510 or Leica SP2 AOBS SE) and processed using Adobe 
Photoshop software. 
Transfection and lentiviral transduction. The lentiviral shRNA expression 
plasmids Mission pLKO.1-puro (control) and Mission shRNA-cSrc (Sigma-Aldrich), 
were used in combination with the envelope plasmid pMD.G, and packaging 
plasmid pCMVR8.91. Packaging, envelope, and shRNA vector plasmids were co-
transfected into HEK293 cells. Viral supernatants harvested after 72 h, filtered and 
incubated with target HeLa cells for 48 h at 37°C. Puromycin was used to select 
for individual clones. The knock-down was verified by immunoblot and/or real-time 
RT-PCR. 
Transfection of siRNA duplexes and plasmid DNA. HeLa cells seeded in 
24- or 6-well plates were transfected with 60 nM of control siRNA-D (sc-44232 
Santa Cruz Biotechnology) or specific siRNAs for NMHC-IIA or NMHC-IIB 
depletion, using Lipofectamine RNAiMax (Invitrogen) following manufacturer’s 
instructions. Assays were performed 48 h later. Sequences of siRNAs are 
provided in Table 4. For transient protein expression, HeLa cells were seeded in 
24-well plates (1x105 cells/well), 6-well plates (4x105 cells/well), or 10 cm dishes 
(3x106 cells/dish), and transfected at 90% confluency with 500 ng, 2.5 µg or 15 µg 
of plasmid DNA, respectively, using Lipofectamine 2000 (Invitrogen). Assays were 
performed 24 h later. For rescue assays, HeLa cells were transfected with NMHC-
IIA-si#2 and 24 h later transiently transfected with plasmids encoding siRNA-
resistant GFP-NMHC-IIA-WT. 
Kinase Assay. Kinase assays were performed using the Src Assay Kit (17-
131, Millipore), following manufacturer’s instructions. Anti-GFP-
immunoprecipitated fractions from HEK293 cells expressing GFP-NMHC-IIA 
variants were incubated (10 min, 30 ºC) with 10 units of recombinant Src (14-117, 
Millipore), in 30 µl of kinase reaction buffer supplemented with 9 µl of 
Manganese/ATP Cocktail and 10 µCi γ32P-ATP (PerkinElmer). Reactions including 
a Src-specific substrate or lacking Src were used as controls. Reactions were 
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precipitated with 40% TCA and spotted onto P81 phosphocellulose paper squares, 
washed three times with 0.75% phosphoric acid, once with acetone and 
transferred to microtubes containing UniverSol liquid scintillation cocktail (MP 
Biomedicals). Incorporation of 32P was determined in a Wallac 1450 MicroBeta 
TriLux liquid scintillation counter (PerkinElmer), as counts per minute (cpm). 
Radioactivity measurements were performed in duplicate in two independent 
assays. 
Statistical analyses. Statistical analyses were performed with Prism 6 
software (GraphPad Software, Inc.). One-way ANOVA with post hoc testing 
analyses were used for pair-wise comparison of means from at least three 
unmatched groups. Two-tailed Student's t-test was used to compare means of two 
samples and one-sample t-test to compare with samples arbitrarily fixed to 100. 
Differences were not considered statistically significant for p value ≥ 0.05. 
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I. RESULTS 
 
I.A. NMHC-IIA is tyrosine-phosphorylated in response to bacterial infection.  
 
To identify new host proteins undergoing tyrosine phosphorylation (pTyr) in 
response to Lm and which could affect Lm cellular infection, we compared the 
pTyr protein profiles of Lm-infected and non-infected (NI) HeLa cells. Cell extracts 
were collected at different time points post inoculation and subjected to 
immunoprecipitation (IP) using anti-phosphotyrosine antibodies (anti-pTyr). IP 
fractions were resolved by SDS-PAGE followed by silver staining. Bands showing 
variable intensities in Lm-infected versus NI cells were excised and processed for 
mass spectrometry identification. A band corresponding to a ≈250 kDa protein and 
displaying increased intensity throughout the infection (Fig. 1A) was identified as 
the human non-muscle myosin heavy chain IIA (NMHC-IIA) (data not shown). 
To validate this result, HeLa and Caco-2 cells were incubated with Lm for 
different time periods and the presence of NMHC-IIA in anti-pTyr IP fractions was 
assessed by immunoblot using NMHC-IIA specific antibodies. We detected a time-
dependent increase of NMHC-IIA in IP fractions from Lm-infected cells (Fig. 1B). 
Levels of NMHC-IIA in pTyr fraction increased 3.5-fold after 60 minutes of Lm 
incubation with HeLa cells and 15-fold in Caco-2 cells upon 20 minutes of Lm 
infection (Fig. 1B). Levels of NMHC-IIA in whole cell lysates (WCL) were not 
affected by infection (Fig. 1B), showing that increased levels of NMHC-IIA in IP 
samples are not related to an augmentation of NMHC-IIA expression. Incubation 
of HeLa cells with the non-pathogenic species Listeria innocua (Li) for 60 minutes 
only induced a small enrichment of NMHC-IIA in the anti-pTyr IP fractions as 
compared to Lm (Fig. 1C). In addition, NMHC-IIA was barely detected in IP 
fractions from HeLa cells stimulated by E. coli DH5a  or latex beads (Fig. 1C). 
Altogether, these results indicate that the enrichment of NMHC-IIA in the pool of 
pTyr proteins is associated to the pathogenic features of Lm and is not a broad 
cellular response to any extracellular stimuli. 
To investigate whether the same response could be induced upon infection 
with other human bacterial pathogens, HeLa cells were incubated for 4 h with: the 
extracellular pathogenic E. coli EPEC and EHEC; or the invasive E. coli K12 
expressing the Yersinia pseudotuberculosis (Yp) invasin (K12-inv) (Isberg and 
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Falkow 1985), an infection model allowing the study of signaling pathways 
triggered downstream the invasin-integrin interaction. As co mpared to NI 
conditions, NMHC-IIA appeared slightly increased in anti-pTyr IP fractions from 
EPEC- and EHEC-infected cells. Strikingly, K12-inv induced a robust enrichment  
of NMHC-IIA in IP samples that is abolished in cells incubated with bacteria 
harboring a disrupted invasin-encoding gene (K12-∆inv, Fig. 1D). For comparison 
 
 
Figure 1. NMHC-IIA is tyrosine-phosphorylated in response to human bacterial pathogens. 
(A) Silver-stained acrylamide gel showing the tyrosine phosphorylation profiles of non-infected (NI) 
and Lm-infected HeLa cells, for the indicated periods of time. Total tyrosine-phosphorylated 
proteins were immunoprecipitated with an anti-pTyr antibody. Molecular weight standards are 
indicated. Arrow shows a protein band with increased intensity over the time of infection and 
identified by mass spectrometry analysis as NMHC-IIA. (B) HeLa and Caco-2 cells were left non-
infected (NI) or incubated with Lm and harvested at indicated time points post-infection (p.i.). 
Tyrosine-phosphorylated proteins were immunoprecipitated (IP: pTyr) from whole cell lysates 
(WCL) and NMHC-IIA was detected by immunoblot (NMHC-IIA) in IP fractions and WCL. Detection 
of actin protein levels served as loading control. Bottom panels show quantifications of NMHC-IIA 
signals from at least 3 independent experiments in WCL and IP fractions of NI and Lm-infected 
HeLa (60 min p.i.) and Caco-2 (20 min p.i.) cells. (C) HeLa cells were left NI or incubated with 
either Lm, L. innocua (Li) (top panels), E. coli DH5a (Ec) or latex beads (bottom panels). Tyrosine-
phosphorylated proteins were immunoprecipitated from WCL recovered at different time points and 
NMHC-IIA was analyzed by immunoblot in IP fractions and WCL. (D) HeLa cells were left NI or 
incubated, for 4 h, with pathogenic E. coli (EPEC and EHEC) and E. coli K12 expressing a 
functional (inv) or mutated variant (∆inv) of Y. pseudotuberculosis invasin. Cells were also 
incubated with Lm for 1 and 4 h (right panel). Tyrosine-phosphorylated proteins were 
immunoprecipitated and NMHC-IIA detected by immunoblot in IP fractions and WCL. 
Quantifications of NMHC-IIA signals for each IP fraction related to WCL are indicated (ratio). 
Values represent the mean of three independent experiments. (E) NMHC-IIA was 
immunoprecipitated (IP: NMHC-IIA) from WCL of NI and Lm-infected (Inf, 60 min) HeLa cells. 
Tyrosine-phosphorylated proteins (pTyr) and NMHC-IIA were detected in immunoprecipitates. As 
control, NMHC-IIA and actin were also detected in WCL. 
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cells were also incubated with Lm for 1 and 4 h (Fig. 1D). These results indicate 
that the enrichment of NMHC-IIA in the pool of pTyr proteins is an event triggered 
by several human bacterial pathogens. 
Our data suggest that bacterial infection either induces the direct NMHC-IIA 
pTyr or stimulates its interaction with a protein that undergoes itself pTyr. To 
address this issue, endogenous NMHC-IIA was immunoprecipitated from NI and 
Lm-infected HeLa cells and pTyr proteins were detected by immunoblot. A band 
showing a consistent 1.5-fold increase in intensity in infected samples was 
detected at the molecular weight of NMHC-IIA (Fig. 1E). Immunoprecipitated 
levels of NMHC-IIA were similar in NI and Lm-infected cells. These results support 
a direct pTyr of NMHC-IIA triggered by Lm infection. 
 
I.B. NMHC-IIA-pTyr induced by Lm cellular infection requires the activity of 
Src tyrosine kinase.  
 
Considering our previous findings revealing the key role of the tyrosine kinase 
Src during Lm invasion (Sousa et al. 2007), we addressed the role of this kinase in 
NMHC-IIA-pTyr in the context of Lm infection. Prior to Lm incubation, HeLa cells 
were treated with PP1, an inhibitor of Src family kinases, or with Y-27632, an 
inhibitor of the serine/threonine kinase ROCK that regulates NMHC-IIA activity 
through the phosphorylation of the regulatory light chain of myosin II and limits Lm 
internalization (Kirchner and Higgins 2008). Given that NMHC-IIA-pTyr is hardly 
detected by using anti-pTyr antibodies in immunoblot, cell lysates were subjected 
to anti-pTyr IP assay and NMHC-IIA was detected in IP fractions. The increase in 
NMHC-IIA-pTyr induced by Lm infection of non-treated cells (NT) was abolished in 
PP1-treated cells while being not affected by Y-27632 treatment (Fig. 2A), 
suggesting that NMHC-IIA-pTyr requires Src kinase activity and occurs 
independently from ROCK activity. In addition, we interfered with Src activity by 
overexpressing a Src kinase-dead variant (Src-KD) (Wilson et al. 1989). Levels of 
NMHC-IIA-pTyr induced by Lm infection were assessed in HeLa cells non-
transfected (NT), transfected with an empty plasmid (Ctr) or overexpressing Src-
KD. In contrast to NT and Ctr cells showing increased levels of NMHC-IIA-pTyr 
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upon Lm infection, in cells overexpressing Src-KD the NMHC-IIA-pTyr was almost 
undetectable (Fig. 2B).  
 
 
Figure 2. The activity of Src kinase is required for NMHC-IIA tyrosine phosphorylation upon 
Lm cellular infection. (A) HeLa cells pre-treated with PP1 (10 µM) or Y-27632 (50 µM) during 30 
min, were left NI or incubated with Lm for 1 h (Inf) in the presence of the same concentrations of 
drugs. Non-treated (NT) HeLa cells were used as control. (B) HeLa cells non-transfected (NT), 
transfected with a control empty plasmid (Ctr) or with a Src kinase dead (Src-KD)-encoding 
plasmid. (C) HeLa cells stably expressing an shRNA control (sh Ctr) or a specific shRNA targeting 
Src expression (sh Src). Cells in B and C were left NI or incubated with Lm for 1 h (Inf). In A, B and 
C, total tyrosine-phosphorylated proteins were immunoprecipitated and NMHC-IIA was detected by 
immunoblot in IP fractions and WCL. Detection of actin levels served as loading control. Src protein 
levels were also confirmed by immunoblot. (D) Efficiency of Src depletion in sh Src HeLa cells was 
assessed by immunoblot using actin protein detection as loading control (left panel) and by qRT-
PCR (right panel). Src mRNA expression is represented relative to the expression of control 
HPRT1. In sh Ctr cells, the relative expression was arbitrarily fixed to 1. 
 To further confirm these data, we targeted the expression of endogenous 
Src by using specific shRNAs. We observed that, Lm-induced NMHC-IIA-pTyr 
occurred in shRNA control (sh Ctr) and was clearly diminished in shRNA Src 
expressing (sh Src) HeLa cells, in which Src expression is reduced by 60% (Fig. 
2C and 2D). Altogether, these data demonstrate that Src activity is required for 
NMHC-IIA-pTyr triggered by bacterial infection. 
 
I.C. Host Src kinase phosphorylates NMHC-IIA in tyrosine residue 158.  
 
The NMHC-IIA amino acid sequence includes 34 tyrosine residues, most of 
which located in the myosin motor domain (Fig. 3A). To identify the NMHC-IIA 
tyrosine residues phosphorylated by Src upon Lm infection, we used combined in 
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silico approaches (NetPhos 2.0 and NetPhosK). Nine tyrosine residues were 
predicted as potentially phosphorylated, among which only the tyrosine in position 
158 (Y158) was a putative substrate for Src kinase (Fig. 3B). To assess these in 
silico predictions and taking into account that Lm-induced NMHC-IIA-pTyr requires 
Src kinase activity (Fig. 2), we determined if NMHC-IIA-pTyr occurs upon Lm 
infection of cells ectopically expressing either GFP-tagged NMHC-IIA-Y158F (in 
which Y158 residue was replaced by a phenylalanine), NMHC-IIA-Y190F 
(harboring the same amino acid substitution in position 190, randomly selected 
and unrelated to in silico predictions) or NMHC-IIA-WT (wild type NMHC-IIA). Lm 
infection of non-transfected (NT), NMHC-IIA-WT- and NMHC-IIA-Y190F-
overexpressing cells generated increased levels of NMHC-IIA-pTyr as compared 
to NI cells, while the overexpression of NMHC-IIA-Y158F largely limited Lm-
induced NMHC-IIA-pTyr (Fig. 3C). Exogenous NMHC-IIA-WT and NMHC-IIA-
Y190F were occasionally detected in anti-pTyr IP fractions of Lm-infected cells 
(data not shown). Levels of endogenous NMHC-IIA were comparable in the 
different conditions and GFP fusion proteins were expressed similarly in NI and 
infected cells (Fig. 3C). These results corroborate in silico predictions and suggest 
the central role of Y158 in NMHC-IIA-pTyr triggered upon infection. To validate our 
results, total lysates from NI and Lm-infected cells were probed with an antibody 
raised against a peptide comprising phosphorylated Y158 residue of NMHC-IIA 
(pY158). In agreement with our data, levels of NMHC-IIA-pY158 were 1.5-fold 
increased in Lm-infected cells (Fig. 3D). In addition, samples enriched in NMHC-
IIA phosphopeptides from NI and Lm-infected cells were analyzed by mass 
spectrometry. A phosphopeptide spanning Y158 (amino acid 142 to 165, 
KRHEMPPHIYAITDTAYRSMMQDR) was detected at m/z 3025.37 [M-H]- (Fig. 3E, 
cluster I) and at 3041.36 [M-H]- with an oxidized methionine (Fig. 3E, cluster II). In 
infected samples, the area of cluster I that is correlated with the abundance of the 
corresponding phosphopeptide, was 4.8-fold increased. Cluster II appeared 2.1-
fold more abundant in Lm-infected samples as compared to NI. Cluster I was 
further characterized and validated by MS/MS sequencing. Altogether our data 
show that phosphorylation occurs in position Y158. 
We further evaluate whether NMHC-IIA-pTyr occurs specifically on Y158 
through Src activity, performing an in vitro kinase assay. GFP-NMHC-IIA-WT or 
Y158F ectopically expressed in HEK293 cells were highly enriched through 
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immunoprecipitation using an anti-GFP antibody and incubated with purified Src 
kinase and γ-32P-ATP. A synthetic peptide substrate for Src was used as positive 
control. In the absence of kinase, the control peptide (Ctr) and IP fractions of 
NMHC-IIA-WT and Y158F showed residual levels of γ-32P-ATP incorporation. In 
the presence of Src kinase, the NMHC-IIA-WT enriched IP fraction and the control 
peptide became radiolabeled while the radioactivity incorporation in the NMHC-IIA-
Y158F enriched sample remained at a basal level (Fig. 3F). 
Altogether these results strongly suggest that Y158 of NMHC-IIA is a 
substrate for Src kinase, becoming phosphorylated in response to Lm infection, 
and put forward the putative role of this event in cellular infection. In addition, Y158 
appears extremely conserved among species ranging from Saccharomyces 
cerevisiae to Homo sapiens (Fig. 3G), pointing the broad importance for Y158 in 
the regulation of highly conserved canonical functions of NMHC-IIA. 
 
 
Figure 3. NMHC-IIA tyrosine residue in position 158 is phosphorylated in response to Lm 
infection. (A) Schematic representation of NMHC-IIA showing the distribution of tyrosine residues 
(red bars). Tyrosine residues in position 158 (Y158) and 190 (Y190) are highlighted. ATP-binding 
site, motor and tail domains are indicated. (B) In silico predictions obtained from NetPhos 2.0 and 
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NetPhosK servers, for tyrosine phosphorylation potential (score) and putative kinase involved. The 
position and amino acid environment of tyrosine residues showing a phosphorylation potential 
above the threshold (score >0.5) are indicated. (C) HeLa cells expressing the wild type GFP-
NMHC-IIA (WT) and the mutants GFP-NMHC-IIA-Y158F (Y158F) or GFP-NMHC-IIA-Y190F 
(Y190F) were left NI or incubated with Lm for 1 h (Inf). NMHC-IIA was detected by immunoblot in 
anti-pTyr immunoprecipitates and WCL. Detection of GFP indicates similar expression levels of 
NMHC-IIA constructs and actin levels served as loading control. (D) HeLa cells were left NI or 
incubated with Lm for 1 h (Inf). Total cell extracts were used in immunoblot using an antibody 
raised against NMHC-IIA-pY158. Total levels of NMHC-IIA were detected using an anti-NMHC-IIA 
antibody and a-tubulin levels were used as loading control. Bottom panel show quantification of 
NMHC-IIA-pY158 signals from 3 independent experiments in NI and Lm-infected HeLa cells. (E) 
Mass spectra from NMHC-IIA acquired after phosphopeptide enrichment from NI and Inf HeLa 
cells. Two peak clusters marked as I (monoisotopic peak at m/z 3025.37 [M-H]-) and II 
(monoisotopic peak at m/z 3041.36 [M-H]- with oxidized methionine) were detected. The 
corresponding NMHC-IIA peptide (aa 142 to 165) is indicated and Y158 highlighted. The area of 
the clusters in NI and Inf conditions is indicated between parentheses. (F) Anti-GFP IP fractions 
obtained from WCL of HEK293 cells expressing either GFP-NMHC-IIA-WT (WT) or GFP-NMHC-
IIA-Y158F (Y158F) were used in in vitro Src kinase assays. A synthetic peptide was used as 
positive control (Ctr). Incorporation of radiolabeled γ-32P-ATP was measured in CPM (counts per 
minute) for each condition. Results are representative of two independent experiments. (G) 
Comparative analysis of the NMHC-IIA amino acid sequence from different species, focused in the 
region encompassing the tyrosine on position 158. 
 
I.D. Inhibition of NMHC-IIA activity affects intracellular levels of Lm.  
 
To assess the role of NMHC-IIA activity in cellular infection, we measured 
intracellular levels of Lm following chemical inhibition of NMHC-IIA. Blebbistatin 
(Blebb), a specific inhibitor of myosin II activity (Straight et al. 2003), was added 
(10 or 100 µM) to HeLa and Caco-2 cells and Lm infection efficiency was 
quantified by gentamicin protection assays. As control we used an inactive form of 
blebbistatin [(+)Blebb]. Lm intracellular levels were increased by 2- to 8-fold, in a 
dose-dependent manner in both cell lines, following treatment with the active [(-
)Blebb] as compared to the inactive enantiomer of blebbistatin (Fig. 4A). Untreated 
and inactive blebbistatin-treated cells showed similar levels of intracellular Lm 
(data not shown). Our data are in agreement with a previous report showing that 
blebbistatin treatment of L2 cells increases Lm adhesion and invasion (Kirchner 
and Higgins 2008). Recruitment of NMHC-IIA and formation of actin foci at Lm 
entry sites were both detected in control (DMSO) and active blebbistatin-treated 
(Blebb) HeLa cells (Fig. 4B). While the percentage of Lm-associated cells 
remained similar in both conditions, the percentage of cells showing Lm-actin foci 
increased in the presence of active blebbistatin (Fig. 4C). Together, our results 
indicate that the ATPase activity of NMHC-IIA is not required for its localization to 
the sites of Lm uptake and does not influence the interaction of Lm with host cells. 
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However, inhibition of NMHC-IIA ATPase activity fosters the formation of Lm-actin 
foci, which correlates with increased rates of intracellular bacteria. 
 
 
Figure 4. Lm intracellular levels increased upon inhibition of NMHC-IIA activity. (A) Levels of 
intracellular Lm were assessed by gentamicin protection assay and CFU counting, in HeLa and 
Caco-2 cells treated with 10 or 100 µM blebbistatin (Blebb). Graph shows the fold-increase of 
intracellular Lm determined as the ratio of intracellular bacteria in cells treated with the active 
versus the inactive enantiomer of blebbistatin. (B) Single confocal sections of HeLa cells infected 
with Lm in the presence of DMSO (control) or 50 µM active Blebbistatin. Infected cells were 
immunolabelled for NMHC-IIA (green) and Lm (blue) and stained for actin (red). (C) 
Immunofluorescence scoring of DMSO- and active Blebbistatin-treated HeLa cells associated to 
Lm and showing Lm-associated actin foci. Results are means±SD from three independent 
experiments, each done in duplicate. Statistically significant differences are indicated: * p<0.05. 
 
I.E. Reduced expression of NMHC-IIA increases the level of intracellular 
Lm.  
To further address the role of NMHC-IIA in Lm cellular infection, levels of 
adherent and intracellular Lm were quantified by gentamicin protection assays in 
NMHC-IIA-depleted HeLa cells, using two siRNAs (si#1 and si#2). In accordance 
with data described above, levels of intracellular Lm increased 2-fold in NMHC-IIA-
depleted (IIA-si#1 and IIA-si#2) as compared to control siRNA-transfected cells 
(Ctr) (Fig. 5A). NMHC-IIA depletion assessed by immunoblot reached 85% in si#1-
transfected cells and 65% when using si#2 (Fig. 5A). Levels of adhered Lm were 
also augmented in NMHC-IIA-depleted cells (data not shown). 
Immunofluorescence analysis of Lm-infected NMHC-IIA-depleted cells revealed a 
2-fold increase in the percentage of cells associated to Lm and a 3-fold increase in 
the percentage of cells showing Lm-associated actin foci (Fig. 5B). The number of 
bacteria and actin foci per cell were also increased in NMHC-IIA-depleted cells 
(Fig. 5C), correlating with increased levels of intracellular bacteria. Our data 
indicate that, while Lm association to cells does not require NMHC-II activity it is 
modulated by NMHC-IIA itself probably through the interaction with other proteins. 
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To discard the hypothesis that increased levels of intracellular Lm detected in 
NMHC-IIA-depleted cells could result from the overexpression of the isoform B of 
non-muscle myosin heavy chain (NMHC-IIB), we confirmed that expression levels 
of NMHC-IIB were similar in NMHC-IIA-depleted cells and control cells (Fig. 5D). 
In addition, we found that Lm intracellular levels decreased 3-fold in NMHC-IIB-
depleted HeLa cells (Fig. 5E), suggesting that NMHC-IIA and IIB play opposite 
roles in Lm infection and thus undermining the possibility of their mutual functional 
replacement. 
 
 
Figure 5. Depletion of NMHC-IIA facilitated Lm cellular infection. (A) Intracellular levels of Lm 
assessed by gentamicin protection assay in HeLa cells non-transfected (NT) or transfected with 
either control siRNA (Ctr) or NMHC-IIA-specific siRNAs (si#1 and si#2). Efficiency of NMHC-IIA 
knockdown was assessed by immunoblot and quantified. Indicated values (Normalized expression) 
are relative to actin and NMHC-IIA expression levels in NT cells. (B) Percentage of control (Ctr) or 
NMHC-IIA-depleted cells (IIA-si#1) associated to Lm and showing Lm-associated actin foci, 
evaluated by immunofluorescence scoring. (C) Number of bacteria and actin foci per cell in control 
and NMHC-IIA-depleted conditions. (D) Depletion of NMHC-IIA does not affect the expression of 
NMHC-IIB. NMHC-IIB expression levels were evaluated by immunoblot in NMHC-IIA-depleted (IIA-
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si#1) as compared to control (NT and Ctr) cells. Actin was used as loading control. (E) Intracellular 
levels of Lm were assessed by gentamicin protection assay in HeLa cells transfected with either 
control siRNA (Ctr) or NMHC-IIB-specific siRNA (IIB-si). Efficiency of NMHC-IIB knockdown was 
assessed by immunoblot using actin protein detection as loading control. (F) Expression of NMHC-
IIA was restored in si#2-depleted cells through the expression of a siRNA-resistant GFP-NMHC-IIA 
(NMHC-IIA-siRes). Intracellular levels of Lm assessed by gentamicin protection assay in HeLa 
cells expressing different levels of NMHC-IIA are shown. Non-treated and NHMC-IIA-depleted cells 
expressing a wild type GFP-NMHC-IIA (NMHC-IIA-WT) were used as controls. Endogenous 
NMHC-IIA silencing and GFP-NMHC-IIA expression was evaluated by immunoblot. Detection of 
actin levels served as loading control. (G) Western blot showing expression levels of endogenous 
(anti-NMHC-IIA, M8064, Sigma-Aldrich) and ectopically expressed NMHC-IIA (anti-GFP, B2, Santa 
Cruz Biotech) in HeLa cells transfected either with GFP-NMHC-IIA-WT or GFP-NMHC-IIA-siRes 
expression vectors. (H) Intracellular levels of L. innocua expressing inlB (Li-inlB), E. coli K12 
expressing the invasin (K12-inv) and Y. pseudotuberculosis (Yp) were assessed by gentamicin 
protection assay in HeLa cells transfected with either control siRNA (Ctr) or NMHC-IIA-specific 
siRNA (IIA-si#1). In panels A and F, the number of intracellular Lm in NT cells was normalized to 
100% and those in siRNA-transfected cells were expressed as relative values to NT cells. In 
panels E and H, numbers of intracellular bacteria were normalized to 100% in Ctr cells and 
expressed as relative values in the other conditions. Results shown in panels A, B, C, E, F and H 
are means±SEM of at least three independent experiments, each done in triplicate. Statistically 
significant differences are indicated: * p<0.05, ** p<0.01 and *** p<0.001.  
 
To definitively reinforce our findings and exclude potential uncontrolled off-
target effects, we performed gentamicin protection assays following gene rescue 
experiments. We created a siRNA-resistant GFP-NMHC-IIA construct (NMHC-IIA-
siRes) by introducing silent point mutations within the si#2 target sequence. We 
found that increased levels of intracellular Lm detected upon NMHC-IIA depletion 
(IIA-si#2) dropped to control levels in NMHC-IIA-depleted cells expressing NMHC-
IIA-siRes (Fig. 5F). In contrast, the expression of NMHC-IIA-WT in NMHC-IIA-
depleted cells did not restore control levels of intracellular Lm. Immunoblot 
analysis confirmed that the expression of endogenous NMHC-IIA was diminished 
in the presence of si#2 and that ectopically expressed NMHCH-IIA was only 
detected in NMHC-IIA-siRes-transfected cells (Fig. 5F). However, in absence of 
si#2, both NMHC-IIA-WT and siRes variants are expressed at similar levels (Fig. 
5G). Together these results confirm that the increase in Lm intracellular levels 
observed in NMHC-IIA-depleted cells is specifically due to NMHC-IIA depletion. 
To analyze whether the role of NMHC-IIA on intracellular levels of bacteria 
was specific for Lm or could be broadened to other bacterial infectious processes, 
we performed gentamicin protection assays using Li expressing InlB (Li-inlB), the 
major internalin driving Lm entry in HeLa cells (Pizarro-Cerda et al. 2012); K12-inv 
and Yp. Numbers of intracellular Li-inlB were not significantly different in NMHC-
IIA-depleted and Ctr cells (Fig. 5H). In contrast, levels of intracellular K12-inv and 
Yp were significantly lower in NMHC-IIA-depleted cells (Fig. 5H). Our data indicate 
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that NMHC-IIA is specifically triggered by pathogenic Lm and is independent of an 
InlB-mediated uptake. By the contrary, the invasin-mediated uptake requires 
NMHC-IIA. Interestingly, NMHC-IIA and IIB were shown to be required for SopB-
mediated invasion of Salmonella (Hanisch et al. 2011). Our findings, together with 
published reports, reveal that NMHC-IIA plays opposite roles in different infection 
models: while it is required for an utmost Yp and Salmonella infection, it has a 
restrictive role in Lm cellular infection. 
 
I.F. The function of NMHC-IIA in Lm infection relies on the phosphorylation 
of its tyrosine 158. 
 
We reported above two important observations: 1) NMHC-IIA is tyrosine 
phosphorylated by Src kinase upon Lm incubation with cells, and 2) Lm 
intracellular levels are increased in conditions of NMHC-IIA depletion or inhibition 
of its activity, demonstrating that NMHC-IIA activity limits Lm infection. To 
investigate whether both findings could be interconnected we evaluated levels of 
intracellular bacteria under conditions where NMHC-IIA-pTyr does not occur. We 
used cells with compromised Src activity (PP1 treatment and Src-KD 
overexpression) and cells expressing an NMHC-IIA non-phosphorylable variant 
(NMHC-IIA-Y158F). Levels of intracellular Lm showed a 2.5-fold increase in PP1-
treated HeLa cells as compared to control DMSO-treated cells (Fig. 6A). In 
agreement, we observed an increase in Lm intracellular levels in cells expressing 
Src-KD (Fig. 6B). Inversely, intracellular levels of K12-inv decreased 2-fold in PP1-
treated cells (Fig. 6C), as previously reported (Alrutz and Isberg 1998). Increased 
levels of intracellular Lm detected in conditions of Src inactivation and thus in 
absence of NMHC-IIA-pTyr, correlates with our data showing that reduced levels 
or inactivation of NMHC-IIA resulted in increased numbers of intracellular Lm. Our 
data also suggest an association between the role of NMHC-IIA in Yp invasin-
mediated uptake and invasin-triggered NMHC-IIA-pTyr. 
To further confirm the role of NMHC-IIA-pTyr in the Lm cellular infection, we 
evaluated intracellular levels of Lm in HeLa and COS-7 cells transiently expressing 
either the GFP-NMHC-IIA-WT (WT) or the non-phosphorylable variant GFP-
NMHC-IIA-Y158F (Y158F). Contrarily to HeLa cells, COS-7 cells naturally lack 
NMHC-IIA expression, therefore allowing the overcoming of effects from the 
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endogenous protein. Equivalent expression levels of both constructs were verified 
by flow cytometry and immunoblot (data not shown). Lm intracellular rates were 
determined by gentamicin protection assays in cell populations containing about 
50% of transfected cells. As compared to NMHC-IIA-WT, the expression of 
NMHC-IIA-Y158F led to increased levels of intracellular Lm in both cell lines (Fig. 
6D). Thus, NMHC-IIA-Y158F expression recapitulates the increase of intracellular 
Lm in NMHC-IIA-depleted or inactivated cells. Furthermore, both GFP-NMHC-IIA-
WT and GFP-NMHC-IIA-Y158F showed the same localization and accumulate at 
the site of Lm entry in HeLa cells (Fig. 6E).  
 
Figure 6. NMHC-IIA phosphorylation in tyrosine 158 is required to limit Lm cellular infection. 
(A and B) Intracellular levels of Lm assessed by gentamicin protection assays in the presence of 
10 µM PP1 (A) or in HeLa cells expressing Src-KD (B). (C) Levels of intracellular K12-inv were 
assessed by gentamicin protection assay in HeLa cells treated with 10 µM of PP1. (D) Intracellular 
levels of Lm were assessed by gentamicin protection assays in HeLa and COS-7 cells expressing 
either GFP-NMHC-IIA-WT (WT) or GFP-NMHC-IIA-Y158F (Y158F). Results shown in panels A, B, 
C and D are means±SEM of three independent experiments, each done in triplicate Numbers of 
intracellular bacteria were normalized to 100% in control cells and expressed as relative values in 
the other experimental conditions. Statistically significant differences are indicated: * p<0.05, ** 
p<0.01. (E) Single confocal section of COS-7 cells ectopically expressing either GFP-NMHC-IIA-
WT or Y158F variants incubated with Lm for 1 h and stained for actin (phalloidin, red) and DNA 
(DAPI, blue) (scale bar 10 µm). 
These results indicate that, whereas NMHC-IIA subcellular localization and 
recruitment to the site of bacterial uptake are unrelated to Y158, the 
phosphorylation of this specific NMHC-IIA tyrosine plays a key role in restraining 
Lm infection. 
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I. DISCUSSION 
 
Pathogens interfere with host phosphorylation cascades to foster adhesion, 
invasion and intracellular survival. Here, we searched for new host proteins 
undergoing tyrosine phosphorylation upon Lm infection. We showed that NMHC-
IIA is tyrosine phosphorylated in response to Lm as well as to other human 
bacterial pathogens such as EPEC, EHEC and K12-inv. In Lm infection, this 
previously unknown tyrosine phosphorylation event is triggered by Src kinase on 
residue Y158 of NMHC-IIA, and limits intracellular bacterial levels. 
Myosin II activity is regulated by phosphorylation events in serine and 
threonine residues of the regulatory light chain (Vicente-Manzanares et al. 2009). 
NMHC-IIA also undergoes serine and threonine phosphorylations, which regulate 
the assembly of myosin II filaments in vitro and are thought to control subcellular 
localization of NMHC-IIA and contractility that depends on the actin-crosslinking 
activity of NMHC-IIA (Vicente-Manzanares et al. 2009). While NMHC-IIA was 
detected in studies aiming to unravel the global phosphotyrosine signaling in 
cancer tissues (Rikova et al. 2007, Guo et al. 2008), its tyrosine phosphorylation 
has never been characterized. Our data constitutes the first report showing and 
characterizing NMHC-IIA-pTyr. Our preliminary in silico analysis suggest an 
important and broad role for NMHC-IIA pTyr in position 158: 1) Y158 is highly 
conserved among species ranging from Saccharomyces cerevisiae to Homo 
sapiens, 2) an in silico study suggested that the residue Y163 of muscle myosin 
heavy chain (matching Y158 in NMHC-IIA) could be phosphorylated (Harney et al. 
2005), 3) Y158 is located in the motor domain of NMHC-IIA nearby the ATP-
binding pocket and 4) analysis of the crystal structure of myosin motor domain 
(Dominguez et al. 1998) showed that Y158 is exposed at the surface of the protein 
and is thus accessible for phosphorylation. Thus, we hypothesize that the 
phosphorylation of NMHC-IIA Y158 could modulate NMHC-IIA activity most 
probably by affecting its ability to bind and/or hydrolyze ATP. However at this point 
any other mechanism could be envisaged. In addition it is likely that NMHC-IIA-
pTyr in Y158 occurs in specific physiological conditions engaging NMHC-IIA 
activity and thus plays a role in the regulation of the highly conserved canonical 
functions of NMHC-IIA. The functional and structural outcomes of such 
modification are now critical to elucidate. 
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Our data suggest that, upon infection, only a small pool of NMHC-IIA becomes 
phosphorylated in Y158, probably concentrated in a restricted subcellular 
localization and/or interacting with specific partners, which would impact infection. 
Yet, we observed that both NMHC-IIA-WT and Y158F concentrated around 
bacteria at the entry site. We also found that phosphorylation of Y158 does not 
affect the phosphorylation of the myosin regulatory light chain (our unpublished 
data), that is achieved by MLCK and is required for activation of myosin II motor 
activity (Vicente-Manzanares et al. 2009). Interestingly, Src was previously shown 
recruited to membrane blebs where it associates with MLCK and myosin II (Barfod 
et al. 2005, Barfod et al. 2011). In response to cell swelling, Src and MLCK form a 
complex in which Src activates MLCK and both regulate a compensatory 
membrane retrieval that requires myosin II (Barfod et al. 2011). It is thus 
conceivable that Src and MLCK could work together to fine-tune the activity of 
myosin II in the context of infection. 
Myosin II isoforms were recently involved in viral and bacterial infections either 
promoting or limiting pathogen progression. However their role in such processes 
is still mainly descriptive. NMHC-IIA is required for KSHV and HSV1 entry into 
cells (Arii et al. 2010, Valiya Veettil et al. 2010, Chakraborty et al. 2012), facilitates 
Salmonella invasion and regulates its intracellular growth (Wasylnka et al. 2008, 
Hanisch et al. 2011) and promotes Chlamydia dissemination (Hybiske and 
Stephens 2007). Conversely, myosin II limits bacterial cell-to-cell spread by 
restraining Lm protrusion formation (Rajabian et al. 2009) and participating in the 
formation of Shigella-associated septin cages (Mostowy et al. 2010). NMHC-IIB is 
involved in the formation of actin-rich structures that accumulate near the 
Salmonella-containing vacuole and restrain bacterial intracellular multiplication 
(Odendall et al. 2012). Altogether, these data suggest that the different outcomes 
associated with myosin II function during infection are probably related to the 
cellular machinery engaged in the various infectious processes. Our results 
indicate that NMHC-IIA activity limits Lm infection most probably hindering cellular 
invasion by interfering with the formation of Lm-induced actin foci. NMHC-IIA-
depleted or inactivated cells were reported to lose cytoplasm cohesion and show 
increased membrane activity and plasticity (Cai and Sheetz 2009, Cai et al. 2010). 
These phenotypes could thus suggest that the increased numbers of intracellular 
Lm observed in such cells would be greatly due to the disruption membrane 
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rigidity. However, if this was the case, cells displaying low NMHC-IIA activity 
should be more permissive to any extracellular pathogen, which was not observed 
in KSHV (Valiya Veettil et al. 2010), HSV1 (Arii et al. 2010) and Salmonella 
(Hamon and Cossart 2011) infections. In addition, we show here that NMHC-IIA 
sustains invasin-mediated Yp infection and the invasion rate of Li expressing InlB 
was not significantly increased by NMHC-IIA-depletion, thus excluding a non-
specific cell invasion mechanism. 
NMHC-IIA participates in cellular processes associated to phosphotyrosine 
signaling, which are largely usurped by bacteria, namely Lm and Yp (Veiga and 
Cossart 2006), during infection. It 1) regulates protrusion formation and cell 
migration through the generation of actin retrograde flow (Cai et al. 2006, 
Giannone et al. 2007), 2) is required for integrin-mediated adhesion maturation 
(Choi et al. 2008), 3) controls cell-cell adhesion promoting E-cadherin clustering 
and stabilizing cellular junctions (Smutny et al. 2010), and 4) it governs the 
polarization of epithelial cells generating forces to maintain the epithelia (Bertet et 
al. 2004). Whether NMHC-IIA is pTyr in these processes is unknown. 
In intercellular junctions, NMHC-IIA is critical for the E-cadherin localization 
(Smutny et al. 2010) and Src activation is required for actin polymerization at cell-
cell contacts (McLachlan et al. 2007), as it is during E-cadherin-mediated Lm 
invasion (Sousa et al. 2007). Interestingly, Src activation and recruitment of c-Cbl 
are key events to control c-Met signaling (Organ and Tsao 2011). Our data show 
that Src activity restricts intracellular levels of Lm in HeLa cells in which Lm uptake 
is mainly mediated by c-Met and rise the hypothesis that Src is acting through the 
tyrosine phosphorylation of NMHC-IIA to inhibit entry. Remarkably, in KSHV 
infection, which depends on integrin and Src activation (Chandran 2010), NMHC-
IIA interacts with the ubiquitin ligase c-Cbl (Valiya Veettil et al. 2010). The complex 
c-Cbl- NMHC-IIA associates with the receptor tyrosine kinase EphA2 that amplifies 
Src signaling to promote viral macropinocytosis (Chakraborty et al. 2012). It is thus 
possible that c-Cbl, which is required for Lm infection (Veiga and Cossart 2005), 
associates with NMHC-IIA and c-Met to modulate Lm infection through tyrosine 
phosphorylation events. To invade cells, Yp binds β1-integrin (Isberg 1990), which 
via its cytoplasmic tail interacts with NMHC-IIA to regulate cell migration (Rivera 
Rosado et al. 2011). As in adhesion and cell migration processes (Destaing et al. 
2011), during Yp infection the engagement of β1-integrin leads to the activation of 
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Src kinase (Bruce-Staskal et al. 2002) that could also act on NMHC-IIA triggering 
its tyrosine phosphorylation at the site of bacterial attachment thereby promoting 
Yp infection. 
Our data open new perspectives in the regulatory mechanisms governing 
NMHC-IIA functions in infection and physiological cellular processes. Further work 
should reveal whether NMHC-IIA-pTyr affects its motor activity, binding partners 
and/or the formation of actomyosin filaments. 
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II. NMHC-IIA-INTERACTING PROTEINS 
 
The proposed restrictive function of NMHC-IIA in Lm infection requires 
further understanding of its role and possible integration in a signaling cascade 
that would be activated during infection. To address this issue, we undertook two 
approaches to identify novel NMHC-IIA protein partners: a high-throughput 
approach and a candidate-based approach. The high-throughput approach was 
based on a yeast two-hybrid (Y2H) screen (Fields and Song 1989) that was 
performed by HYBRIGENICS Services with the aim of revealing unknown protein 
partners.  
The candidate-based approach was achieved by biochemical techniques, 
namely immunoprecitpitations, to confirm interactions with suspected partners.  
The Y2H principle is based on the reconstitution of a functional transcription 
factor (TF) (Figure 13A) when two proteins interact. The process occurs in 
genetically modified yeast strains, in which the TF-mediated expression of a 
reporter gene leads to growth on a selective medium and detection of positive 
colonies. Examples of reporter genes are HIS3, which encodes a protein involved 
in histidine biosynthesis, to select positive clones on a medium without histidine; 
and lacZ, that encodes a β-galactosidase that signals for positive colonies through 
the generation of a blue precipitate in the medium, resulting from the hydrolysis of 
X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside).  
To setup a Y2H screen, the coding DNA sequence of the protein of interest  
(“bait”) is fused to the coding sequence of the TF DNA binding domain (DBD) (the 
fusion protein is named “bait”). In parallel, a library of cDNA fragments is fused to 
the TF activation domain (AD) coding sequence (fusion proteins called “prey”) 
(Figure 13B). Both bait and prey plasmids are introduced in particular yeast cells 
that will be mated and plated in selective medium allowing the detection of positive 
colonies (Figure 13C). When interaction occurs between bait and prey proteins, 
the DBD and AD are brought together and a functional TF is reconstituted 
upstream of the reporter gene leading to its transcription (Figure 13B). Common 
protein fusions use the DBD and AD of Gal4, a yeast transcription activator. The 
bacterial DNA-binding protein LexA is also used as a DBD in combination with the 
AD of Gal4.  
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For the purpose of our screen, we selected the C-terminal  domain of 
NMHC-IIA (Leu837 to Glu1960) as the bait protein fragment (Figure 14) based on 
several criteria: 1) the motor domain function and its actin-interacting partners are 
well-described; 2) myosins from different classes share high homology through 
motor domains, increasing the probability of common binding partners; 3) the tail 
fragment subdomains are responsible for functional diversity among myosins and 
tail domain interactions with different cytoplasmic proteins have been described; 
and 4) the tail domain dictates the cellular localization of a particular myosin 
through its interaction with specific partners (Kussel-Andermann et al. 2000, 
Dahan et al. 2012, Majewski et al. 2012, Ramagopal et al. 2013). As a source of 
potential interacting prey proteins, we selected a library of human placental 
proteins, based on the fact that the placenta is a fast-growing and proliferative 
organ with high protein diversity and expression levels, and is particularly relevant 
for Lm pathology (Mylonakis et al. 2002, Lecuit et al. 2004, Lecuit 2005). 
 
 
Figure 13. Schematic diagram of the Y2H system. (A) Transcription factor (TF)-mediated 
activation of gene expression in physiological conditions. (B) A positive interaction between bait 
and prey proteins leads to reconstitution of a functional TF and promotes reporter gene expression. 
(C) Bait and prey plasmids are transformed into a yeast cell and if an interaction occurs, a yeast 
colony will grow in the selective medium. 
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II. EXPERIMENTAL PROCEDURES 
 
Y2H screening. A DNA fragment containing the coding sequence for the 
NMHC-IIA tail domain (Leu837 to Glu1960) was fused with the Gal4 DBD coding 
sequence to generate our bait plasmid. Similarly, prey plasmids were generated 
from fusions of the Gal4 AD coding sequence with fragments from a randomly 
primed human placental cDNA library. Yeast cells containing a bait plasmid were 
mated with a population of yeast cells, each containing a unique prey plasmid. 
Upon growth of bait and prey plasmid-transformed yeast cells in selective media, 
positive clones were identified through both LacZ activity and HIS3 expression. 
The positive prey fragments were identified by PCR and DNA sequencing at their 
5’ and 3’ sites and the obtained DNA sequences were used to identify the 
corresponding gene in the GenBank database (NCBI), using BLASTN (Rain et al. 
2001, Formstecher et al. 2005).  
 Cell lines and culture media. Jeg-3 cells were grown in Eagle’s minimal 
essential medium (EMEM) with L-glutamine supplemented with 2 mM non-
essential amino acids, 2 mM sodium pyruvate and 10% fetal bovine serum (FBS). 
HeLa and HEK293 cells were cultivated in Dulbecco’s modified Eagle medium 
(DMEM) with glucose (4.5 g/L), L-glutamine and 10% FBS at 37ºC in a 5% CO2 
atmosphere. All media and reagents were purchased from Lonza. 
 Plasmids and antibodies. GFP-NMHC-IIA-WT (pEGFP-C3:CMV-GFP-
NMHC IIA) was obtained from Addgene. Mouse monoclonal anti-actin AC-15 
(A5441) and rabbit polyclonal anti-NMHC-IIA (M8064) were purchased from 
Sigma; mouse monoclonal anti-NMHC-IIA (ab55456) was purchased from Abcam; 
rabbit polyclonal anti-β-Adaptin (H-300; sc-10672) was obtained from Santa Cruz 
Biotechnology; and mouse monoclonal anti-Hsp56 (ADI-SRA-1400) was 
purchased from Enzo Life Sciences. HRP-conjugated secondary antibodies were 
from P.A.R.I.S (Cambridge Bioscience).  
 Immunoprecipitation (IP). HeLa cells were washed in phosphate-buffered 
saline (PBS) and lysed for 30 minutes on ice with lysis buffer [50 mM Tris-HCl pH 
7.5, 150 mM NaCl, 2 mM EDTA, 1 mM AEBSF (Uptima-Interchim), cOmplete 
Protease Inhibitor Cocktail (Roche Pharmaceuticals), 1% NP-40]. Lysates were 
centrifuged at 15,000 g for 10 min at 4°C and the supernatants were cleared with 
a 20% (v/v) suspension of Protein G Sepharose beads (GE Healthcare) or Protein 
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G magnetic beads (Millipore) for 1 h at 4°C. Cleared lysates were 
immunoprecipitated with anti-NMHC-IIA, anti-β-Adaptin or anti-Hsp56 (10 µg per 
mg of total protein extracts) overnight at 4°C with agitation. Immune complexes 
were captured with 60 µl of a 20% (v/v) suspension of Protein G Sepharose or 
magnetic beads for 3h at 4°C and washed twice in wash buffer (50 mM Tris-HCl 
pH 7.5, 150 mM NaCl, 2 mM EDTA, 1 mM AEBSF, cOmplete Protease Inhibitor 
Cocktail, 0.2% NP-40). Immunoprecipitated complexes were recovered in Laemmli 
buffer (0.25 mM Tris-HCl pH 6.8, 8% SDS, 40% glycerol, 10% β-mercaptoethanol, 
0.008% bromophenol blue). Proteins were denatured at 95ºC for 10 min and 
resolved by SDS–PAGE. 
  
 
Figure 14. Schematic representation and amino acid sequence of NMHC-IIA. Fragment 
used as bait for Y2H (L837 to E1960) is depicted in blue. Motor and tail domains are 
highlighted in red and green, respectively. 
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II. RESULTS 
 
II.A. Selection of candidate prey proteins  
 
Our Y2H screen allowed the analysis of 232 million interactions, of which 97 
were positive and validated by HYBRIGENICS. From these 97 positive 
interactions, we selected five prey protein candidates for confirmation of NMHC-IIA 
interaction (Table 4 and Figure 15). Three were selected based on their high 
interaction reliability rating: ZNF12, SMPD4 and AFF1. For the purpose of this 
work, two other candidate proteins, β-adaptin and Hsp56, although low-rated, 
were also selected considering that they have been described in the literature to 
be associated with NMHC-IIA function and relevant in the context of infection. 
 
  
 
Figure 15. Schematic representation of the Selected Interaction Domains (SID) of the 
selected prey proteins. Amino acid sequences of the five selected Y2H targets are depicted 
in blue and prey protein domains that interacted with the bait fragment is depicted in yellow. 
 
 
Table 4.  Prey proteins selected from Y2H screen for further study.  
Target protein Rating1 Interaction domain Frame Number of hits Nucleotide Amino acid 
ZNF12 A 33-2891 422-597 In-frame 23 
SMPD4 B 57-745 33-243 In-frame 4 
AFF1 C 2331-3143 872-1046 In-frame 2 
β-Adaptin D 711-1430 238-476 In-frame 1 
Hsp56 D 57-1150 20-383 In-frame 1 
1 Ratings range from A to F:  A, B, C and D represent very high, high, good and moderate 
confidence interactions, respectively. D-rated interactions correspond to weakly detected 
interactions usually identified through one unique prey fragment (just one hit in the Y2H).  
Ratings E and F are considered very low confidence interactions and were not considered in 
this study (Rain et al. 2001). 
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II.B. Validation of NMCH-IIA interactions with β-adaptin and Hsp56 
 
The β-adaptin and Hsp56 interactions with NMHC-IIA positively identified in 
a yeast system needed to be further validated by other methods in human cell 
lines. We first aimed to verify whether both proteins were endogenously expressed 
in cells lines used in our laboratory, some of which relevant for infection. To do 
that, we performed WB on total extracts from HeLa, HEK-293 and JEG-3 cells and 
detected the proteins using specific antibodies. We observed that both β-adaptin 
(105 kDa) and Hsp56 (56 kDa) were expressed in the three cell lines (Figure 16). 
 
 
Figure 16. Expression of Y2H target proteins in human cell lines. WB analysis of (A) 
Hsp56 and (B) β-adaptin expression in HeLa, HEK293 and Jeg-3 cells. Actin used as control. 
 
We then performed immunoprecipitation (IP) assays for further validation of 
the selected NMHC-IIA interactions. Although IP of NMHC-IIA from non-infected 
HeLa cell extracts was not highly efficient, WB analysis confirmed that both β-
adaptin (105 kDa) and Hsp56 (56 kDa) co-immunoprecipitate with NMHC-IIA 
(Figure 17A). Reversely, IP of Hsp56 and β-adaptin revealed that NMHC-IIA co-
eluted with the immunoprecipitated proteins: NMHC-IIA was detected at 1/100 
Hsp56 IP (Figure 17B) and 1/50 β-adaptin (Figure 17C) conditions. These results 
confirm biochemically the NMHC-IIA-β-adaptin and NMHC-IIA-Hsp56 interactions. 
Further evaluation of these interactions is currently ongoing in the context of 
infection, and it would be interesting to verify if bacterial infection potentiates or not 
this phenotype.  
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4.4    Optimization of the immunoprecipitation of NMIIA  
 
To biochemically confirm the results obtained in the Y2H assay we performed 
immunoprecipitation assays (IPs). This method consists in precipitating a selected 
protein, using a specific antibody, from a whole cell lysate and this way retrieve its 
interacting partners (Dwane and Kiely, 2011). 
Two different IPs were optimized to serve as platforms to be used in the confirmation of 
the interactions: the IP of endogenous NMIIA and the IP of ectopically expressed GFP-
tagged NMIIA, in which the protein is overexpressed in cells. 
The first task was to optimize the IP of endogenous NMIIA from HeLa and Jeg-3 cell 
lysates. 
Figure 14 Expression levels of AFF1 (A), Hsp56 (B),  β-Adaptin (C), SMPD4 (D) and ZNF12 (E) in HeLa, HEK 293 and 
Jeg-3 cell lines. For each cell line 20 μg  of  total  protein were used for WB analysis. Detection of actin protein levels was 
used as loading control.  
A B C 
D E 
A B 
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Figure 17. Interaction of NMHC-IIA with Hsp56 and β-adaptin. (A) Immunoprecipitation 
(IP) of NMHC-IIA in HeLa cell extracts and WB detection of β-adaptin and Hsp56 in the co-
immunoprecipitates (co-IP). (B) IP of Hsp56 or (C) β-adaptin in HeLa cell extracts and WB 
detection of NMHC-IIA in the co-IP. Actin was used as loading control. IP efficiency was 
evaluated by comparison with total cell extracts (INPUT). FT: IP flow-through fraction. 
 
II.C. Candidate-based approach (Gp96-MIIA) 
 
Previous work in our lab identified Gp96 as a host receptor for Lm virulence 
factor Vip (Cabanes et al. 2005). We have also shown that Lm infection increased 
the cell surface expression of Gp96 and we characterized the interaction between 
Vip and Gp96 at the molecular level (Martins et al. 2012) (see also Annex I of this 
thesis). Considering these results, we wanted to see if NMHC-IIA would also 
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reproducible result. In 6 out of 9 experiments β-adaptin was associated with NMIIA, 
thus validating the Y2H screen data (Figure 19A and 19B). Hsp56 also appeared to co-
IP with NMIIA in the majority of the performed experiments (Figure 19A and 19B). 
Together these results validate the data from Y2H indicating the direct binding between 
NMIIA and Hsp56 and β-adaptin. 
Detection of actin protein levels in Figure 20B suggests different levels of protein 
between the two samples. Nevertheless the both targets appeared in the IP fraction 
associated with NMIIA (Figure 19B). 
In some experiments: NMIIA associated with the isotype control antibody (Figure 20A), 
β-adaptin associated with the isotype control antibody (Figure 20B) and Hsp56 did not 
appear associated with NMIIA (Figure 20C). 
However, considering all the experiments performed we overall consider that NMIIA 
interacts with both proteins and thus we focused the rest of the work performed in this 
project on these two targets.  
 
 
 
 
Figure 19 Evaluation of the interaction between: NMIIA and Hsp56 and NMIIA and β-adaptin. Detection of actin protein 
levels was used as loading control. (A) NMIIA was immunoprecipitated from 500 μg. β-adaptin and Hsp56 associated 
with NMIIA. (B) NMIIA was immunoprecipitated from 600 μg β-adaptin and Hsp56 also seem to co-IP with NMIIA. 
 
 
 
 
 
 
 
 
 
 
A B 
FCUP 
Identification of novel non-muscle myosin IIA (NMIIA) interacting partners 
43 
 
NMIIA. It was possible to observe an association between Hsp56 and NMIIA in the 
1:100 ratio (Figure 21A) but it was difficult to detect the association with β-adaptin 
(Figure 21B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21 Optimization  of  the  IP  of  Hsp56  and  β-adaptin. Three antibody to total protein ratios were tested Detection of 
actin protein levels was used as loading control. (A) NMIIA seems to co-IP with Hsp56 in the 1:100 ratio condition. (B) 
Detection of NMIIA is difficult in the 1:50 ratio.  
 
 
Scale-up IPs were performed for Hsp56 and β-adaptin using 300 and 500 μg of total 
protein, respectively, with the optimized 1:100 ratio. As controls: an antibody against 
the c-Myc tag (IP of Hsp56) and an isotype control antibody (IP of β-adaptin) were 
used. IP of Hsp56 (Figure 22A) was less efficient than the IP of β-adaptin (Figure 22B). 
Detection of NMIIA was performed by immunoblot. In Figure 22A very faint band 
corresponding to NMIIA appeared in the lane of the IP fraction. In Figure 22B NMIIA is 
B 
A 
A 
B 
C 
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interact with Gp96 during infection. Interestingly, we observed that upon infection, 
there was an increase in the amount of Gp96 immunoprecipitated with NMHC-IIA 
(Figure 18), suggesting that this protein association is potentiated by Lm infection. 
Other experiments have shown that NMHC-IIA interaction with Gp96 is triggered 
by Lm infection in a LLO- and Ca2+-dependent manner (Mesquita, F.S. 
unpublished results) but independent on Vip. Recently, mass spectrometry 
analysis of Gp96 immunoprecipitated protein fraction allowed the identification of a 
protein as being NMHC-IIA.  
 
 
Figure 18: Gp96 co-immunoprecipitates with NMHC-IIA. HeLa cells were left non-infected (NI) 
or incubated with Lm and harvested 60 minutes post-infection (Inf). NMHC-IIA was 
immunoprecipitated (IP: NMHC-IIA) from whole cell lysates (WCL) and NMHC-IIA and Gp96 were 
detected by immunoblot in WCL and IP: NMHC-IIA fractions.  
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II. DISCUSSION 
 
Based on the results presented above we can propose three valid 
candidates as NMHC-IIA protein interactors: β-adaptin, Hsp56 and Gp96. 
 
β-adaptin 
 
Adaptins are subunits of the clathrin–adaptor protein (AP) complex, a family 
of heterotetrameric protein complexes that mediate the sorting of membrane 
proteins in both exocytic and endocytic pathways connecting the trans-Golgi 
complex (GC), endosomes, lysosomes, and the plasma membrane (Boehm and 
Bonifacino 2001, Nakatsu and Ohno 2003). Each AP complex has four subunits: 
two large subunits (one from α1 to α4 and another from β1 to β4), one medium 
subunit (µ1 to µ4) and one small subunit (σ1 to σ4) (Figure 16). To date four AP 
complexes have been described: AP1, AP2, AP3 and AP4. The AP2 acts 
specifically at the plasma membrane in endocytic processes while AP1, AP3 and 
potentially AP4 are associated with the formation of clathrin-coated vesicles from 
intracellular membranes (Blondeau et al. 2004, Robinson 2004).  
 
 
AP complexes play an important role in the formation of clathrin-coated 
vesicles by recruiting clathrin, as well as in the incorporation of cargo membrane 
proteins into nascent clathrin-coated vesicles by recognizing sorting signals such 
 
Figure 16. Schematic representation of a clathrin-adaptor protein complexes 1 to 4. Each 
complex is composed by four subunits: two large subunits (α and β adaptins), one medium (µ) and 
one small (σ) subunit.  
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as dileucine- and tyrosine-based sorting motifs (Ohno et al. 1995, Heilker et al. 
1996). 
The β-adaptin subunit of AP1 is commonly found inside the cell on the 
cytoplasmic face of clathrin-coated vesicles located at the GC. There, it mediates 
the recruitment of clathrin and the recognition of sorting signals that are located on 
the cytosolic tails of transmembrane cargo molecules. (β) and medium (µ) 
subunits AP1 recognize both tyrosine-based (YXXφ) (Carvajal-Gonzalez et al. 
2012) and dileucine-based ([DE]XXXLL) (Rapoport et al. 1998) sorting signals. 
AP-1 is involved in the basolateral recycling of transmembrane proteins controlling 
viral infection (Diaz et al. 2009) and is required for Lm cell invasion (Pizarro-Cerda 
et al. 2007). Remarkably, NMHC-IIA contains both a dileucine-based sorting motif 
within the tail domain used in our Y2H screen and a tyrosine-based sorting motif 
exactly including its tyrosine-158 that we showed to be phosphorylated upon 
infection. The sorting signal of the YxxΦ type (where Y is tyrosine, x is any amino 
acid, and Φ is any hydrophobic amino acid) mediates protein targeting and 
internalization through tyrosine phosphorylation (Marks et al. 1996), so we 
hypothesize that Y158 phosphorylation might regulate functional properties of NM-
IIA in the interaction with other adaptor or effector proteins namely β-adaptin, that 
also recognizes YxxΦ motifs (Carvajal-Gonzalez et al. 2012). Noticeably, 
regulation of other tyrosine-based sorting motifs occurs through phosphorylation 
(Bonifacino and Traub 2003). 
In addition, β-adaptin, was shown to be recruited at focal adhesions, at the 
leading edges of migrating cells (invadipodia) (Pignatelli et al. 2012). Therefore, it 
is important to continue the study of β-adaptin function and its interaction with NM-
IIA. 
 
Hsp56 
 
Hsp56 is composed of an N-terminal peptidylprolyl cis-trans isomerase 
(PPIase) domain responsible for the chaperoning function in protein folding 
processes (Schiene and Fischer 2000), and a C-terminal tetratricopeptide repeat 
(TPR) domain, which is responsible for mediating protein-protein interactions 
(Goebl and Yanagida 1991). It is considered a high-molecular weight 
immunophilin, a known target of the immunosuppressive drug FK506, and is 
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therefore also named FKBP4 (FK506-binding protein 4). Hsp56 is known to 
associate with other heat shock proteins (Hsp90) and to play a role in the 
intracellular trafficking of hetero-oligomeric protein complexes of steroid receptors, 
between the cytoplasmic and nuclear compartments (Tai et al. 1986). To this 
purpose, Hsp56 binds a motor protein, dynein, allowing the translocation of the 
hormone complex from the cytoplasm to the nucleus (Czar et al. 1994, Pratt and 
Welsh 1994, Galigniana et al. 2001).  Importantly, Hsp90 is a Gp96 paralogue, 
which in turn is a known Lm receptor (Cabanes et al. 2005) and whose subcellular 
localization was shown to be affected during infection (Martins et al. 2012). 
Moreover, we could envision that Lm-induced NMHC-IIA-Gp96 interaction may be 
stabilized by protein complex formation with the chaperone Hsp56. 
One can assume that bacteria by sequestering NM-IIA could interfere with 
either inward or outward vesicular trafficking of any cargo, and facilitate Lm 
infection.  
Moreover, in studies of recurrent spontaneous abortions in women, Hsp56 
gene expression appears decreased in placentas of terminated pregnancies. 
Abortions caused by Lm infection are still not well understood, in particular the 
tropism of the bacteria to this organ (Chen et al. 2014). Therefore, Hsp56 function 
and interaction with NM-IIA are important to evaluate.  
 
Gp96 
 
Gp96 is a chaperone glycoprotein that belongs to the Hsp90 family, and is 
localized within the lumen of the endoplasmic reticulum (ER) (Yang and Li 2005). 
The expression of Gp96 is highly increased in stressful conditions leading to the 
accumulation of misfolded proteins. Gp96 has multiple protein substrates and has 
been implicated in both innate and adaptive immunity. It chaperones antigenic 
peptides, delivers them to antigen-presenting cells (APC), and activates dendritic 
cells (DCs). Importantly, Gp96 is required for the proper folding and cell surface 
distribution of TLRs and integrins (Yang et al. 2007, Wu et al. 2012). 
In particular conditions such as cell activation, necrotic cell death or 
infection, Gp96 is exposed at the cell surface and is often hijacked as a membrane 
protein serving as receptor for bacterial virulence factors. Besides its role as Lm 
receptor, Gp96 is a key mediator in the establishment of various human infections. 
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Neisseria gonorrhoeae surface protein PorBIA interacts with Gp96 allowing an 
increase in adherence (Rechner et al. 2007). Gp96 also serves as receptor for 
enterotoxin A from Clostridium difficile (Na et al. 2008), OmpA expressed at the 
surface of E. coli K1 (Prasadarao et al. 2002, Prasadarao et al. 2003, Maruvada et 
al. 2008) and Als3 invasin of Candida albicans (Liu et al. 2011). In addition Bap, a 
biofilm matrix protein of Staphylococcus aureus, has been shown to prevents 
bacterial entry into epithelial cells through binding to Gp96 receptor (Valle et al. 
2012) 
Some intracellular pathogens use mechanisms that trigger interactions of 
the pathogen-containing compartments with secretory pathway components 
culminating in either pathogen resilience or replication (Canton and Kima 2012). 
Moreover, TTSS bacterial effectors directly manipulate components of the 
secretory pathway that are responsible for intracellular vesicle trafficking (Hilbi and 
Haas 2012). Chlamydia is an obligate intracellular pathogen whose release from 
cells has been described to occur by either cellular lysis or extrusion of the 
bacterial containing vacuoles. Inhibition or depletion of NM-IIA reduced chlamydial 
extrusion (Hybiske and Stephens 2007, Lutter et al. 2013). Gp96-NMHC-A 
interaction in Lm infection was LLO-dependent. Considering that NMHC-IIA, 
described to facilitate vesicle trafficking in membrane repair (Lin et al. 2012), and 
Chlamydia infection findings, one can assume that Lm through secretion of LLO 
manipulates cell membrane integrity and hijack a similar system. It is not known if 
NMHC-IIA is tyrosine-phosphorylated in membrane repair or which are the 
responsible Lm virulence factors for this PTM. Although we have recently 
observed that LLO toxicity induces NMHC-IIA tyrosine phosphorylation (Mesquita, 
F.S. unpublished results). Moreover, increased Shigella infection might correlate 
with Lm-LLO toxicity through the insertion of Ipa proteins into host cell membranes 
(Blocker et al. 1999, Mostowy et al. 2010). How LLO and NM-IIA-Gp96 interaction 
influences membrane extrusion mechanisms in Lm infection will be important to 
address (Koster et al. 2014, Seveau 2014).  
Despite the progress in understanding the roles of Gp96 during infection 
much remains to be learned concerning the mechanisms inducing Gp96-cell 
membrane association and triggering of signaling pathways downstream Gp96 
engagement.  
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All the proposed NMHC-IIA-interacting proteins discussed above are of 
extreme importance for dissecting the intracellular pathways hijacked during 
infection. Moreover, understanding the cellular processes where these proteins 
are involved will allow us to track the respective signaling cascades and define the 
exact role of NMHC-IIA in bacterial infection. 
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III. KERATINS  
 
In our search to identify novel host proteins that would be tyrosine-
phosphorylated in response to Lm, we followed an immunoprecipitation approach 
coupled to protein identification by mass spectrometry. We identified NMHC-IIA 
(described in section I of the results chapter) and an intermediate filament protein, 
keratin 18 (K18).  
Intermediate filaments (IFs) are cytoskeletal polymers whose protein 
properties and intracellular organization provides crucial structural support in the 
cytoplasm and nucleus. Besides functions primarily related to structural integrity of 
cells and tissues, non-mechanical roles for IFs have been ascribed in a highly 
diverse range of cellular functions (Leduc and Etienne-Manneville 2015). These 
include cell adhesion and migration (Ivaska et al. 2007), organelle shaping and 
positioning (Toivola et al. 2005), in modification of various cellular processes, such 
as stress response and tissue growth, through their ability to regulate signaling 
molecules (Pallari and Eriksson 2006, Kim and Coulombe 2007). IFs are regulated 
by post-translational modifications, being phosphorylation the major regulatory 
event reported for these proteins. This regulation leads to the recruitment and 
sequestration of signaling molecules that participate in several cellular functions 
(Hyder et al. 2008). 
Considering IF localization, there are four major types of IF proteins in 
vertebrate cells: epithelial (acidic-type I keratins and basic-type II keratins), 
neuronal (nestin, neurofilament proteins NF-L, NF-M and NF-H), nuclear (lamins 
A, B, and C) and in mesenchymally-derived cells (vimentin, desmin, glial fibrillary 
acidic protein, peripherin)  (Leduc and Etienne-Manneville 2015). 
Keratins represent the typical IF category in epithelial cells, showing a high 
degree of molecular diversity. As part of the epithelial cytoskeleton, keratins are 
important for the mechanical stability and integrity of epithelial cells and tissues 
(Toivola et al. 2015). In contrast to the other IF proteins keiratins only can 
constitute their filamentous stage by heteropolymeric pair formation between a 
type I and type II keratin. Individual keratin proteins deviating from the equimolar 
type I: type II amounts are rapidly degraded (Lu and Lane 1990).  There are 28 
type I keratin-encoding genes (17 epithelial keratins and 11 hair keratins) and 26 
type II keratin-encoding genes (20 epithelial keratins and 6 hair keratins) 
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(Schweizer et al. 2006, Haines and Lane 2012). K18 is typically co-expressed with 
K8, and constitute the primary keratin pair of simple epithelial cells.  
 As members of the IF protein family they share a common tripartite protein-
structure, with a central rod domain of α-helical conformation flanked by non-
helical head and tail domains (Figure 10). Heterodimer formation occurs by 
association of the corresponding rod domains in α-helical coiled-coil conformation. 
The resulting polymerization forms the basic building units of the keratin filaments 
(Omary et al. 2006).  
Besides being static intracellular skeletal structures, some keratins 
modulate intracellular signaling pathways of different dynamic cell processes such 
as cell polarization, migration, protein synthesis and membrane trafficking (Toivola 
et al. 2015). Several keratin variants have been associated with different diseases, 
either caused by gene mutation or altered keratin PTM patterns (Omary et al. 
2009, Pan et al. 2013, Snider and Omary 2014).  
Published data on the involvement of K18 in several bacterial infectious 
processes (Scherer et al. 2000, Carlson et al. 2002, Batchelor et al. 2004, Kumar 
and Valdivia 2008, Rodel et al. 2012, Saberi et al. 2012) supported our decision to 
further study K18 tyrosine phosphorylation and its role in Lm infection. Here I will 
present and discuss our first observations and results concerning K18. 
 
 
Figure 20. Schematic representation of keratin domain structure. Keratins share a common 
domain structure consisting of a conserved α-helical rod domain that is flanked by variable non-
helical head and tail regions. Subdomains of the rod domain (1A/1B/2A and 2B) are interrupted by 
non-helical linkers (L1/L2 and L12). Adapted from (Eriksson et al. 2009). 
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III. EXPERIMENTAL PROCEDURES  
 
Bacterial strains, cell lines and culture media. Lm strain EGDe (ATCC 
BAA-679) was grown in brain heart infusion (BHI) broth (Difco Laboratories, 
Becton, Dickinson and Company, USA) at 37ºC with agitation. Caco-2 cells were 
grown in Eagle’s Minimal Essential Medium with L-Glutamine (EMEM) 
supplemented with 2 mM non- essential aminoacids, 2 mM sodium pyruvate and 
20% fetal bovine serum FBS). HeLa cells were grown in Dulbecco’s modified 
Eagle medium with 4.5 g/L Glucose and L-Glutamine (DMEM) supplemented with 
10% FBS. The cells were grown without antibiotics at 37ºC in a 5% CO2 
atmosphere. All media and products for cell culture were purchased from Lonza. 
Antibodies. Monoclonal antibody raised against phosphotyrosine (clone 
4G10) was purchased from Millipore (05-321). Antibodies to detect K8 (sc-8020), 
K18 (sc-6259) and GAPDH (sc-32233) were obtained from Santa Cruz. Rabbit 
K18 antibody was from Abcam (ab52948). α-Catenin antibody was purchased 
from BD Biosciences (610193). HRP-conjugated secondary antibodies were from 
P.A.R.I.S (Cambridge Bioscience).  
Infection and immunoprecipitation assays. Caco-2 cells were seeded 
onto 75 cm2 flasks and incubated at 37°C in a 5% CO2 atmosphere, until 
confluence. The day of the experiment, cells were washed twice with phosphate- 
buffered saline (PBS) and serum-starved during 5 h at 37°C and 5% CO2. Then, 
cells were either left uninfected or infected with Lm EGDe at a MOI of 200 bacteria 
per cell, during different periods of time. After each time point, cells were washed 
twice with ice-cold PBS and lysed in 1 ml of lysis buffer (1% NP-40, 50 mM Tris pH 
7.5, 150 mM NaCl, 2 mM EDTA, 1 mM AEBSF, PhosSTOP (Roche 
Pharmaceuticals) and Complete Protease Inhibitor Cocktail (Roche 
Pharmaceuticals)). Lysates were centrifuged at 15 000 g for 10 min at 4°C and 
immunoprecipitated with 2 µg of anti-phosphotyrosine antibody (4G10) overnight 
at 4°C. Immune complexes were captured with 50 µl of PureProteome Protein A 
magnetic beads (Millipore) at 4°C and washed three times with wash buffer (0.2% 
NP-40, 50 mM Tris pH 7.5, 150 mM NaCl, 2 mM EDTA, 1 mM AEBSF, 
PhosSTOP, Complete Protease Inhibitor Cocktail). Immunoprecipitated proteins 
were eluted and boiled in Laemmli buffer containing 0.1 mM DTT and 5% β-
mercaptoethanol. 
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Protein identification by mass spectrometry (MS). Protein identification 
was performed by MALDI TOF/TOF mass spectrometry as described (Osorio and 
Reis 2013). Protein bands were excised from SDS-PAGE gels, reduced with 
dithiothreitol, alkylated with iodacetamide and in gel digested with trypsin. Peptides 
were extracted, desalted, concentrated using ZipTips (Millipore), crystallized onto 
a MALDI sample plate and analyzed using a 4700 Proteomics Analyzer MALDI-
TOF/TOF (Applied Biosystems). Peptidic mass spectra were acquired in reflector 
positive mode at a 700-4000 m/z mass window and proteins identified by Peptide 
Mass Fingerprint using the Mascot software (Matrix Science, UK) integrated in the 
GPS Explorer software (ABSCIEX, CA) and searched against the 
SwissProt/UniProt Homo sapiens protein sequence database. The maximum error 
tolerance was 35 ppm and up to two missed cleavages were allowed. 
Immunoblotting. Proteins were resolved by SDS-PAGE and transferred 
onto Nitrocellulose membranes (Hybond ECL, GE Healthcare Life Sciences). 
Membranes were blocked with 5% skimmed milk in buffer A (150 mM NaCl, 20 
mM Tris- HCl pH 7.4 and 0.1% Triton X-100) for 1 h at room temperature and 
incubated overnight with primary antibodies diluted in 2.5% skimmed milk in buffer. 
Membranes were then washed and incubated with mouse or rabbit HRP-
conjugated secondary antibodies for 1 hour. The signal was developed with the 
ECL Chemiluminescent Detection System (Pierce). 
Determination of intracellular bacteria. Infection experiments were 
performed as previously described (Reis et al., 2010). For invasion assays, cells 
were challenged with Listeria at MOI of 50 for one hour. After one hour infection 
the inoculum was removed and cells were treated with 20 µg/ml gentamicin for 90 
min. Cells were further washed three times with PBS, lysed with 0.2% Triton X-100 
and serial dilutions plated for CFU counting. Assays were performed in triplicate 
and repeated 3 times. 
Transfection of siRNA duplexes. HeLa cells seeded in 24 well plates 
were transfected with 60 nM of control siRNA-D (sc-44232, Santa Cruz 
Biotechnology) or specific siRNAs for K8 and/or K18 depletion, using HiPerfect 
Reagent (Qiagen) following manufacturer’s instructions. Assays were performed 
72 h later. K8 (CUGGGAAGGAGGCCGCUAU) and K18 ( 
GAGAGGAGCUAGACAAGUA) siRNA duplexes (Sigma) were transfection into 
Caco-2 cells with the Nucleofector system (Amaxa).  
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III. RESULTS  
 
III.A. K18 tyrosine phosphorylation during infection 
 
Infection experiments were performed for different periods of time, and total 
cell lysates were subject to IPs using 4G10 antibody. Eluates were further 
resolved by SDS-PAGE and visualized by silver staining as described for NMHC-
IIA identification. 
As previously described we searched for bands showing variable intensities 
over the time of infection, indicating differential tyrosine phosphorylation profiles in 
response to bacterial interaction with host cells. Such bands were analyzed by 
mass spectrometry for protein identification. A band extracted from an infection 
experiment in Caco-2 cells was identified as being K18. The spectrum of trypsin-
digested peptides obtained by MS, as well as their corresponding molecular 
masses are represented in Figure 21A. K18 has a molecular weight of 48 kDa, 
which corresponds to the molecular weight of the band extracted from the 
polyacrylamide gel (37-50 kDa).  
We started by analyzing the expression levels of K18 by WB in different cell 
lines relevant for Lm infection studies, such as Caco-2, Jeg-3 and HeLa, and 
confirmed that K18 was expressed in all three cell lines (Figure 21B). 
 
 
Figure 21. Identification and validation of K18 as a tyrosine-phosphorylated protein in 
Lm infection. (A) Trypsin-digested peptides of K18 identified by PMF. (B) Evaluation of the 
expression of endogenous K18 in human cell lines relevant for Lm infection. (C) K18 tyrosine 
phosphorylation in response to Lm infection of Caco-2 cells. IP of tyrosine-phosphorylated 
proteins in total cell extracts (infected and non-infected) with 4G10 and WB detection of K18 
in the immunoprecipitates. 
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To further confirm that K18 is differentially tyrosine-phosphorylated in 
response to infection, experiments with Caco-2 cells incubated with Lm and further 
4G10 IPs of the cell lysates were repeated, as described above, and 4G10 eluates 
were resolved by SDS-PAGE. WB analysis with anti-K18 showed that the amount 
of K18 in the 4G10 IP fraction increases with infection. This result shows that the 
amount of tyrosine-phosphorylated K18 is higher at 20 min post-infection, (Figure 
21C). The total amount of K18 in the different whole cell lysates of non-
immunoprecipitated extracts was unchanged, thus ensuring that the expression of 
total K18 remains the same in the course of the infection. Surprisingly, the 
enrichment of K18 fractions was not observed in phosphotyrosine-
immunoprecipitated fractions of infected HeLa cells (data not shown).  
These results show for the first time that Lm infection induces an increase 
of K18 tyrosine phosphorylation in Caco-2 cells.  
 
III.B. Role of K8 and K18 during infection 
 
The increase in tyrosine phosphorylation of K18 upon Lm infection suggests 
a role for K18 in Lm cellular infection. Therefore we decided to study K8/K18 role 
in Lm infection. 
We first decided to evaluate bacterial entry in cells depleted for K18 and K8, 
through an RNAi approach. Experiments were performed using either K18 or K8 
small interference RNA (siRNA) on Caco-2 and HeLa cells. Cells were harvested 
72h hours after siRNA transfection, and protein depletion assessed by WB for K18 
and K8, using GAPDH as a loading control (Figure 22A).  
While the intracellular levels of Lm were not affected by the depletion of 
K18 and/or K8 in Caco-2 cells (Figure 22B), they were strongly reduced in 
depleted HeLa cells (Figure 22C).  
Given that the early events of Lm infection in HeLa cells are driven by c-Met 
and InlB interaction, these results show that K18/K8 are required during the Lm 
infectious process probably through an InlB-dependent mechanism. Although not 
required in a InlA-dependent pathway, as seen in siRNA experiments in Caco-2 
cell, tyrosine phosphorylation occurs in this cell line suggesting a possible role of 
K8/K18 in processes unrelated with Lm entry. 
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Figure 21. The requirement of K8 and K18 in Lm invasion is cell line-dependent. (A) WB 
detection of the expression levels of K8 and K18 on HeLa (top panels) and Caco-2 (bottom panels) 
cells left non-transfected (NT) or transfected with control (Ctr) or specific siRNAs for K8 (K8-si), 
K18 (K18-si) or both (K8/K18-si). GAPDH was used as loading control. (B and C) Caco-2 (B) and 
HeLa (C) cells were infected with Lm and levels of intracellular bacteria were determined. Bacterial 
counts in NT cells were normalized to 100 and bacterial counts in cells treated with siRNAs are 
expressed as relative values. Results shown are the mean of at least three independent 
experiments. *p<0,05. 
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"Figure 6. The requirement of K8 and K18 in Listeria invasion is cell line dependent. 
(A) Immunoblot showing the expression levels of K8 and K18 on HeLa (top panels) and 
Caco-2 (bottom panels) cells left non-transfected (NT) or transfected with control (Ctr) or 
specific siRNAs for K8 (K8-si), K18 (K18-si) or both (K8/K18-si). GAPDH detection was 
used as loading control. (B, C) Cells were infected with either L. monocytogenes or L. 
innocua InlB and levels of intracellular bacteria were determined. Bacterial counts in NT 
cells were normalized to 100 and b cterial ounts in cells treated with siRNAs are 
expressed as relative values. (D) Cells ere infec ed with L. m nocytogenes for 30’ an  
levels of adherent bacteria were determined. Bacterial counts in NT cells were normalized 
to 100 and bacterial counts in cells treated with siRNAs are expressed as relative values. 
Results shown are the mean of at least three independent experiments. *p<0,05. 
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III. DISCUSSION 
 
We present here the first evidence of increased K18 tyrosine 
phosphorylation in response to Lm infection. Despite K19 and K8 tyrosine 
phosphorylation having already been characterized (Feng et al. 1999, Zhou et al. 
2010, Snider et al. 2013), to our knowledge studies reporting K18 tyrosine 
phosphorylation have not yet been published.  
Functionally, distinct keratins emerged as protein scaffolds, contributors to 
cell size determination, protein synthesis, cell proliferation, organelle transport or 
cell migration. All of these properties are controlled by highly complex patterns of 
phosphorylation and molecular associations (Magin et al. 2007). Keratin 
phosphorylation commonly occurs within the tail and/or head domains.  
Several serine phosphorylation sites and the respective kinases have been 
characterized in K8 and K18, supporting a role in filament solubility and 
reorganization and in regulating keratin interaction to other proteins (Snider and 
Omary 2014). Previous studies suggested a role for K8/K18 in cell spreading and 
motility. In terms of molecular regulation, the head and tail domains of K8 and K18 
contain phosphorylation motifs at serine sites that are recognized by mitogen-
activated protein (MAP) kinase cascades, protein kinase A (PKA) and protein 
kinase C (PKC) (Bordeleau et al. 2010, Busch et al. 2012, Fois et al. 2013). The 
dynamics of K8/K18 phosphorylation is controlled by kinases that are themselves 
involved in signaling pathways. It is suggested that K8/K18 may act as modulators 
of signaling pathways involving integrins at focal adhesions. In fact, it appears that 
K8/K18 depletion interferes with mechano-transduction signaling triggered by 
integrin β1 (Bordeleau et al. 2008). By a functional parallelism between cell 
adhesion molecules, such as cadherin and integrin, it sounds reasonable to 
believe that Lm hijacks cell adhesions through activation of K18. The physiological 
role of K8/K18 in signal transduction, involved in cell motility, might suggest that 
Lm uses these mechanisms in order to promote infection. In the analysis of the 
role of K18/K8 in infection our results show that K18/K8 are required in HeLa 
infection by Lm, pointing to an InlB-dependent mechanism since c-Met is the Lm 
receptor expressed in this cell line. Although not required in a InlA-E-cadherin 
dependent pathway, as seen in siRNA experiments in Caco-2 cells, tyrosine 
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phosphorylation results in this cell line suggest a possible role of K8/K18 in 
processes unrelated with Lm entry (Rotty and Coulombe 2012). 
In what concerns bacterial infection and recruitment/activation of keratins, 
only a few studies were able to show a link between them. Previous studies have 
shown that both Salmonella and EPEC infections require K18. A yeast two-hybrid 
assay revealed K18 as an interacting partner of EPEC virulence factor EspF. 
Furthermore, it was shown that the adaptor protein 14-3-3 co-immunoprecipitated 
with EspF, suggesting that K18, 14-3-3 and EspF may form a complex in EPEC 
infected cells (Viswanathan et al. 2004). Others have identified K18 as a novel Tir-
interacting protein that is recruited to EPEC-induced pedestals (Batchelor et al. 
2004). Moreover, it has been demonstrated that 14-3-3 is recruited to the pedestal 
and can bind specifically to Tir (Patel et al. 2006). Salmonella invasion was 
inhibited in cells expressing dominant negative derivatives of K18. Moreover, 
SspC/SipC effector protein presents K8 and K18 as potential interactors (Scherer 
et al. 2000, Carlson et al. 2002). Furthermore, K18 protects Chlamydia inclusion 
contents from cytoplasmic innate immune system (Kumar and Valdivia 2008, 
Rodel et al. 2012). Contrarily, Helicobacter pylori, was shown to induce apoptosis 
by increasing a CagA-dependent K18 cleavage (Saberi et al. 2012). More recently, 
liver disease caused by hepatitis B viral infections demonstrated that viral 
replication requires K8 (Zhong et al. 2014). Nevertheless, the precise role of K18 
and its partner K8 in infection are still unknown.  
Currently, another PhD student in the laboratory is responsible to 
investigate at the molecular level the involvement of keratins in bacterial infection 
(Cruz, R.; unpublished results). 
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Together with myosin VIIa (Sousa et al. 2004) and myosin VI (Bonazzi et al. 
2011), NM-IIA emerges as a novel class of myosins participating in Lm infection. 
In particular, with this study we found that Src phosphorylates the NMHC-IIA Y158 
residue upon Lm infection and that this PTM impairs Lm cell invasion. We also 
detected NMHC-IIA-pTyr in response to other human bacterial pathogens such as 
EPEC, EHEC and Yersinia, suggesting a central role for NMHC-IIA-pTyr in cellular 
infection. In addition, β-adaptin, Hsp56 and Gp96 were identified as novel NMHC-
IIA-interacting proteins unveiling new paths to further explore NM-IIA function.   
Considering that NMHC-IIA-pTyr occurs during bacterial infection, we 
hypothesized that this PTM was required for the establishment of infection. In the 
case of Lm infection, NMHC-IIA-pTyr kinetics were different in HeLa as compared 
to Caco-2 cells, possibly due to different signaling pathways being engaged by 
Lm. Indeed, in Caco-2 cells, Lm entry occurs mainly through a mechanism 
dependent on InlA/E-cadherin interaction, while Lm is internalized in HeLa cells by 
InlB-mediated c-Met activation. Moreover, invasion of Caco-2 cells by Lm is more 
efficient, which could explain the peak of NMHC-IIA-pTyr occurring at earlier time 
points in this cell line. 
NMHC-IIA-pTyr was also detected in the context of Yersinia, EPEC and 
EHEC cellular infection. When we employed an artificial system (K12-inv) used in 
studies of invasin-mediated entry and invasin-triggered signaling pathways, we 
also observed strong NMHC-IIA-pTyr levels, demonstrating that invasin-mediated 
host cell infection also exploits NHMC-IIA-pTyr. Although to a lesser extent, 
NMHC-IIA-pTyr was also observed in infection by pathogenic E. coli. EPEC 
intimin-induced Tir clustering stimulates TirY474 phosphorylation by the Src-family 
kinase (SFK) c-Fyn, triggering actin polymerization and pedestal formation 
(Hayward et al. 2009) Others demonstrated that cortactin was also required for the 
formation of EPEC pedestals (Cantarelli et al. 2006), while experiments with Src 
and non-phosphorylatable mutants of cortactin showed an impairment in this 
process. This indicates that a dynamic tyrosine phosphorylation of cortactin by Src 
is important for pedestal formation (Huang et al. 1998). It is possible that Src or 
other SFKs could tyrosine-phosphorylate NMHC-IIA in distinct residues to 
differentiate the anti-phagocytic mechanisms triggered by extracellular pathogens 
from the internalization-promoting mechanisms used by intracellular bacteria. Our 
results show that NMHC-IIA-pTyr does not occur exclusively by an InlA- or an InlB- 
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activated signaling pathway, as it is also observed in other pathogen infections. 
Considering Src activation by other pathogens it would be interesting to investigate 
which tyrosine residue is phosphorylated in NMHC-IIA and how Y158F mutation 
could compromise Yersinia, EPEC and EHEC infections.  
 NMHC-IIA Y158 was predicted in silico to be a Src substrate and we 
showed that Y158 phosphorylation is indeed mediated by this tyrosine kinase. Src 
activation is known to be induced by the InlA/E-cadherin interaction, but it was 
never associated with the InlB/cMet internalization pathway. This suggests that 
interactions between other Lm virulence factors and their respective host receptors 
can potentially activate Src and induce NMHC-IIA Y158 phosphorylation. It would 
thus be important to identify and address the effect of other virulence factors in this 
response. 
Our results do not provide a clear correlation between NMHC-IIA-pTyr and 
RLC activation and therefore we might be unraveling a novel functional property of 
NM-IIA, which is dependent on heavy chain tyrosine phosphorylation but 
independent of RLC phosphorylation. It is therefore important to determine how 
the NMHC-IIA-pTyr status relates with the motor activity levels of NM-IIA in the 
context of infection. For this, we should further characterize the NMHC-IIA Y158F 
mutant in relation to NM-IIA motor activation in different cell processes to confirm if 
Y158 phosphorylation functionally diverges from RLC phosphorylation. The 
construction and analysis of structural models of both non-phosphorylated and 
Y158-phosphorylated forms of NM-IIA should improve our knowledge of how the 
dynamic phosphorylation of this residue, located in an α-helix close to the ATP-
binding pocket, would influence the Mg2+-ATPase and actin-binding activity 
required for NM-IIA motor function (Figure 22). Interestingly, blebbistatin, which is 
known to bind NM-IIA close to the ATP-binding pocket, impairs the actin-activated 
Mg2+-ATPase activity and blocks NM-II in a low actin affinity state (Straight et al. 
2003, Kovacs et al. 2004). We postulate that phosphorylation dynamics of Y158 
could have a similar impact. 
We showed that NMHC-IIA is recruited at Lm entry sites. Intriguingly, the 
Y158F mutant is also recruited, suggesting that NM-IIA localization is either 
independent of the fine-tuned tyrosine phosphorylation mechanism or probably 
phosphorylation might happen downstream of its recruitment.  
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NM-IIA has crucial roles in cellular processes requiring force generation and 
membrane reshaping, namely cell membrane tension and cytoplasm cohesion 
(Cai and Sheetz 2009, Cai et al. 2010, Houk et al. 2012). Therefore, Lm locally 
manipulates NM-IIA-dependent membrane integrity and actin foci rearrangements 
to promote infection, while NMHC-IIA activity restricts infection most probably by 
delaying cellular invasion. 
NMHC-IIA has been controversially proposed as an entry receptor for 
Herpes simplex virus-1 (HSV-1) (Arii et al. 2010) and promote viral infection via 
MLCK activation (Antoine and Shukla 2014). In addition, recent findings for the 
same viral family (Kaposi’s sarcoma-associated herpesvirus) support a role for 
NM-IIA in viral signaling at the peri-membrane location through interaction with 
ubiquitin ligase c-Cbl and EphrinA2 (EPHA2) (Valiya Veettil et al. 2010, 
Chakraborty et al. 2012). EPHA2 is tyrosine kinase receptor also shown to interact 
with PI3K and adaptor proteins involved in bacterial infection such as Shc and 
Grb2 (Pandey et al. 1994, Pratt and Kinch 2002). Although our results do not 
depend on InlB expression, c-Cbl can be also recruited trough an alternative Lm-
activated signaling machinery, which would depend on NM-IIA and EPHA2.  
 
Figure 22.  Structure of the Argopecten irradians (scallop) myosin heavy chain (motor and 
neck domains) and essential (ELC) and regulatory (RLC) light chains. Schematic 
representation (adapted from RCSB Protein Data Bank file 1DFL) showing actin- and ATP-binding 
pockets (with bound ATP) as well as the Y160 residue, equivalent to human NMHC-IIA Y158 
residue (Houdusse et al. 2000). 
 116 
Cell migration is regulated by NMHC-IIA through interaction with the 
cytoplasmic tail of β1-integrin. Integrin receptors also have a role in InlB-
dependent Lm invasion and both β1- and β3-integrin participate in bacterial 
internalization (Auriemma et al. 2010). In addition, LapB, which has been shown to 
be required for Lm adhesion and entry, contains an RGD (Arg-Gly-Asp) motif 
responsible for LapB-mediated invasiveness (Reis et al. 2010), which is also a 
core recognition sequence for potential integrin interaction (Reis, O. and Cabanes, 
D. unpublished results). Thus it would be interesting for this study to further 
characterize LapB-integrin interaction and relate it with NM-IIA function and 
tyrosine phosphorylation. 
Increased Lm infection observed in conditions of absence or inactivation of 
NMHC-IIA, can be related with alterations in myosin–actin structures that can 
contribute to surface exposure of a new putative host cell receptor as it was 
described for integrins (Carragher et al. 2006) and also affect receptor 
conformation and/or membrane localization (Rodriguez-Fernandez et al. 2001, 
Shewan et al. 2005, Charrasse et al. 2006, Lawler et al. 2006, Wloka et al. 2013). 
Consequently, a putative receptor could be more accessible leading to increased 
bacterial adhesion and entry. 
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In this project, the use of relevant infection models have deepened the 
molecular understanding of NM-IIA function and regulation. Since cellular 
response to pathogens provided the first evidence showing NMHC-IIA-pTyr and 
given that pathogens produce exacerbated signals, facilitating the dissection of 
signaling pathways, it would be important in the future to characterize in-depth the 
role of NMHC-IIA-pTyr with regard to the NM-IIA canonical functions as well as in 
the context of bacterial infection. NM-IIA-dependent cellular processes triggered 
by physiological stimuli should also be investigated, namely the engagement of 
pathogen-targeted host cell receptors by their cognate ligands (e.g. β1-integrins 
and c-Met. The NM-IIA Y158F mutant will be also an important tool to further 
determine how phosphorylation triggered during infection translates into the 
complex network of NMHC-IIA protein interactions and whether it is the molecular 
basis of the responsible mechanisms. 
NMHC-IIA also presents an immunoreceptor tyrosine-based inhibitory motif 
(ITIM), which is a phosphorylation motif found in a large number of receptors and 
adaptor proteins. The ITIM motif of NMHC-IIA (IFY278YLL) is described to be 
tyrosine-phosphorylated and consequently recruit SHP-1 phosphatase required for 
B cell activation (Baba et al. 2003). Characterization of a possible infection-driven 
Y278 phosphorylation in NMHC-IIA will be a valuable tool to improve our 
knowledge in the differential phosphotyrosine signaling triggered by NM-IIA. 
 To further explore NM-IIA functioning, we identified two novel NMHC-IIA 
partners by Y2H assay: β-adaptin and Hsp56. The central role of NM-IIA in cellular 
functions and the growing evidence pointing to the involvement of NM-IIA in 
bacterial infection, together with the cellular functions attributed to β-adaptin and 
Hsp56, render the NM-IIA-β-adaptin and NM-IIA-Hsp56 interactions significantly 
worthy of being studied in the context of bacterial infection, intracellular trafficking 
and cellular homeostasis.  
Our results provide novel and significant insights to the molecular 
understanding of Lm pathogenesis, NM-IIA function and reveal new protein 
interactions important for intracellular trafficking, protein sorting and proper protein 
cellular localization. Our work contributes to both infection and cell biology fields, 
reiterating the importance of pathogens as tools to uncover novel cell biology 
mechanisms and regulatory pathways. 
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